<SEC-DOCUMENT>0001513162-20-000144.txt : 20200721
<SEC-HEADER>0001513162-20-000144.hdr.sgml : 20200721
<ACCEPTANCE-DATETIME>20200721144122
ACCESSION NUMBER:		0001513162-20-000144
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20200721
DATE AS OF CHANGE:		20200721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239980
		FILM NUMBER:		201038661

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>forms3.htm
<DESCRIPTION>FORM S-3
<TEXT>
<HTML>
<head><title>Form S-3</title> </head> <body vlink=purple link=blue style=TEXT-JUSTIFY-TRIM:punctuation lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>As filed with the Securities and Exchange Commission on July 20, 2020</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>Registration No. 333<font style=BACKGROUND:white>-_______________</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>UNITED STATES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Washington, D.C. 20549</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">FORM&nbsp;S-3</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;<b>REGISTRATION STATEMENT&nbsp;UNDER</b></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>THE SECURITIES ACT OF&nbsp;1933<a name=TAB1 /></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:62.45pt> <td width=175 style="HEIGHT:62.45pt; WIDTH:131.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=369 colspan=2 style="HEIGHT:62.45pt; WIDTH:276.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">BIOMERICA, INC.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(Exact name of registrant as specified in its</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>charter)</font></i></p></td> <td width=175 style="HEIGHT:62.45pt; WIDTH:131.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:59.35pt> <td width=360 colspan=2 style="HEIGHT:59.35pt; WIDTH:3.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;<b><i>Delaware</i></b></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(State or other jurisdiction of</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>incorporation or organization)</font></i></p></td> <td width=360 colspan=2 style="HEIGHT:59.35pt; WIDTH:3.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><i><font style=COLOR:black>&nbsp;95-2645573</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(I.R.S. Employer</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>Identification Number)</font></i></p></td></tr> <tr> <td width=179 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /> <td width=188 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /> <td width=188 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /> <td width=179 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>17571 Von Karman Avenue</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Irvine, California 92614</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>(949) 645-2111 </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(Address, including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices)</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Zackary Irani</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Chairman &amp; Chief Executive Officer</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Biomerica, Inc.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>17571 Von Karman Avenue</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Irvine, California 92614</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>(949) 645-2111 </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><i><font style=COLOR:black>(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in">&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Copies to:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <table width=100% bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=100% style="WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Christopher D. Ivey, Esq.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Jason Lee, Esq.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Stradling Yocca Carlson &amp; Rauth, P.C.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>660 Newport Center Drive, Suite 1600</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Newport Beach, California 92660</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>(949) 725-4000</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Approximate date of commencement of proposed sale to public:</font></b><font style=COLOR:black>From time to time after this Registration Statement becomes effective.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. [&nbsp; &nbsp;] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:3.75pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. [X] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><a name=_Aci_Pg1 />&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [&nbsp; &nbsp;] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ &nbsp;&nbsp;] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. [ &nbsp;&nbsp;] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.[&nbsp;&nbsp; ] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule 12b-2 of the Exchange Act.</p> <div align=center> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr style="HEIGHT:0.1in; PAGE-BREAK-INSIDE:avoid"> <td width=396 style="HEIGHT:0.1in; WIDTH:297pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29 style="HEIGHT:0.1in; WIDTH:0.3in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=202 style="HEIGHT:0.1in; WIDTH:151.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style="HEIGHT:0.1in; PAGE-BREAK-INSIDE:avoid"> <td width=396 style="HEIGHT:0.1in; WIDTH:297pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>Large accelerated filer [ &nbsp;&nbsp;] </p></td> <td width=29 style="HEIGHT:0.1in; WIDTH:0.3in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=202 style="HEIGHT:0.1in; WIDTH:151.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>Accelerated filer [&nbsp; &nbsp;] </p></td></tr> <tr style="HEIGHT:0.1in; PAGE-BREAK-INSIDE:avoid"> <td width=396 style="HEIGHT:0.1in; WIDTH:297pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29 style="HEIGHT:0.1in; WIDTH:0.3in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=202 style="HEIGHT:0.1in; WIDTH:151.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style="HEIGHT:0.1in; PAGE-BREAK-INSIDE:avoid"> <td width=396 style="HEIGHT:0.1in; WIDTH:297pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>Non-accelerated filer [&nbsp;&nbsp;&nbsp;&nbsp; ]</p></td> <td width=29 style="HEIGHT:0.1in; WIDTH:0.3in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=202 style="HEIGHT:0.1in; WIDTH:151.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>Smaller reporting company [X]</p></td></tr> <tr style="HEIGHT:0.1in; PAGE-BREAK-INSIDE:avoid"> <td width=396 style="HEIGHT:0.1in; WIDTH:297pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29 style="HEIGHT:0.1in; WIDTH:0.3in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=202 style="HEIGHT:0.1in; WIDTH:151.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style="HEIGHT:0.1in; PAGE-BREAK-INSIDE:avoid"> <td width=396 style="HEIGHT:0.1in; WIDTH:297pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29 style="HEIGHT:0.1in; WIDTH:0.3in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=202 style="HEIGHT:0.1in; WIDTH:151.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>Emerging growth company [&nbsp; &nbsp;] </p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [&nbsp; &nbsp;] </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 9pt 0pt 0in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-BEFORE:always; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p><font style='FONT-SIZE:2pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:115%'><br clear=all style=PAGE-BREAK-BEFORE:none></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in">&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>CALCULATION OF REGISTRATION FEE</font></b></p> <table width=100% bordercolor=transparent style="WIDTH:100%; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.25pt" cellpadding=0 cellspacing=0> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=36% style="WIDTH:36.64%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'><b></b><b>Title of each class of securities to be registered </b></p></div></td> <td width=14% style="WIDTH:14.98%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Number of shares to be registered</font></b><b><sup><font style="FONT-SIZE:12.5pt; COLOR:black">(1)</font></sup></b></p></div></td> <td width=16% style="WIDTH:16.38%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Proposed maximum offering price per share</font></b><b><sup><font style="FONT-SIZE:12.5pt; COLOR:black">(2)(5) </font></sup></b></p></div></td> <td width=16% style="WIDTH:16%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Proposed maximum aggregate offering price</font></b><b><sup><font style="FONT-SIZE:12.5pt; COLOR:black">(1)(3) </font></sup></b></p></div></td> <td width=16% style="WIDTH:16%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Amount of registration fee </font></b><b><sup><font style="FONT-SIZE:12.5pt; COLOR:black">(4)(5)</font></sup></b></p></div></td></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=36% style="WIDTH:36.64%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Primary Offering</font></b></p></td> <td width=14% style="WIDTH:14.98%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=16% style="WIDTH:16.38%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=36% style="WIDTH:36.64%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:11.25pt; PADDING-RIGHT:0.25pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock, $0.08 par value per share</font></p></td> <td width=14% style="WIDTH:14.98%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&#150;</font></p></td> <td width=16% style="WIDTH:16.38%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&#150;</font></p></td> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$90,000,000</font></p></td> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$7,634.22</font></p></td></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=36% style="WIDTH:36.64%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Secondary Offering</font></b></p></td> <td width=14% style="WIDTH:14.98%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=16% style="WIDTH:16.38%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=36% style="WIDTH:36.64%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:11.25pt; PADDING-RIGHT:0.25pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock, $0.08 par value per share </font></p></td> <td width=14% style="WIDTH:14.98%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>571,429 </font></p></td> <td width=16% style="WIDTH:16.38%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$10.83 </font></p></td> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$6,188,576. 07</font></p></td> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$803.28 </font></p></td></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=36% style="WIDTH:36.64%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>TOTAL</font></b></p></td> <td width=14% style="WIDTH:14.98%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=16% style="WIDTH:16.38%; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$96,188,576.07 </font></p></td> <td style="PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>$8,437.50 </font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=hangingindent />&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:107%; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>(1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>In connection with the primary offering, this registration statement covers the registration of such indeterminate number of shares of common stock as may be offered and sold from time to time by the Registrant, which shall have an aggregate initial offering price not to exceed $90,000,000. In connection with the secondary offering, this registration statement registers a maximum of 571,429 shares of common stock to be offered and sold by the selling stockholder identified in this registration statement. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:107%'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:107%; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>(2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>The proposed maximum initial offering price per share for the primary offering will be determined by the Registrant, from time to time, in connection with the issuance by the Registrant of the shares registered hereunder.&nbsp; <br>&nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 8pt 0.5in; LINE-HEIGHT:107%; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>(3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>The proposed maximum aggregate offering price will be determined from time to time by the Registrant in connection with, and at the time of, the issuance of the shares and is not specified pursuant to General Instruction II.D. of Form S-3. Shares of common stock of the Registrant in the proposed maximum aggregate offering amount of $45,000,000 were previously registered on the registrant&#146;s registration statement on Form S-3 (File No. 333-219130) (the &#147;Prior Registration Statement&#148;), which was originally filed with the Securities and Exchange Commission (the &#147;SEC&#148;) on June 30, 2017 and declared effective by the SEC on July 20, 2017, $31,184,736 of which remain unsold as of the date hereof (the &#147;Unsold Securities&#148;). Pursuant to Rule 415(a)(6) under the Securities Act, the offering of the Unsold Securities will be registered pursuant to this registration statement, to the extent they remain unsold as of the effective date of this registration statement. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 8pt 0.5in; LINE-HEIGHT:107%; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>(4)&nbsp; With respect to the primary offering, the registration fee has been calculated pursuant to Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price of the shares to be sold in the primary offering. Pursuant to Rule 415(a)(6) under the Securities Act, this registration statement covers a total of $31,184,736 of Unsold Securities registered pursuant to the Prior Registration Statement, but which remain unsold as of the date hereof. The Unsold Securities are being carried forward to and registered on this registration statement. In connection with the registration of the Unsold Securities on the Prior Registration Statement, the registrant previously paid a registration fee of $4,047.78. Accordingly, the &#147;Amount of registration fee&#148; for the primary offering above reflects only the filing fee attributable to the $58,815,264 of new securities registered on this Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, (i) the registration fee is being carried forward to this registration statement and will continue to be applied to the Unsold Securities, and (ii) the offering of the Unsold Securities registered on the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. If the registrant sells any of the Unsold Securities pursuant to the Prior Registration Statement after the date of the initial filing, and prior to the date of effectiveness, of this registration statement, the registrant will file a pre-effective amendment to this registration statement, which will reduce the number of Unsold Securities included on this registration statement.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 8pt 0.5in; LINE-HEIGHT:107%; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:107%' lang=EN-IN>(5)&nbsp; With respect to the secondary offering, estimated solely for the purpose of calculating the registration fee has been calculated pursuant to Rule 457(c) under the Securities Act based on the average of the high and low prices of the common stock on the NASDAQ Capital Market on July 17, 2020, or $10.83, which is a date within five business days of the filing date of this registration statement. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%'>&nbsp;</p>  <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of&nbsp;1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a), may determine.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=PGBRK /><a name=FTR /><a name=GLFTR /><a name=PN />&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><font style='FONT-SIZE:2pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=PAGE-BREAK-BEFORE:always></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=HDR /><a name=GLHDR />&nbsp;</p></div><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=PAGE-BREAK-BEFORE:always></font> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'><b><font style=COLOR:red>The information in this prospectus is not complete and may be changed. We and the selling stockholder may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style=COLOR:red>PRELIMINARY PROSPECTUS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style=COLOR:red>SUBJECT TO COMPLETION, DATED July 20, 2020</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">$90,000,000</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center>&nbsp;</p> <p style=page:WordSection2 align=center><img width=3548 height=600 style="HEIGHT:43px; WIDTH:304px" src=logo.jpg></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">BIOMERICA, INC.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">Common Stock</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">571,429 Shares of Common Stock </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">Offered by the Selling Stockholder</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>This prospectus relates to a primary offering by us, and a secondary offering by the selling stockholder identified in this prospectus.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>From time to time, we may offer and sell shares of our common stock with total gross proceeds of up to $90,000,000. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>This prospectus also relates to the offer and resale of up to an aggregate of 571,429 shares of our common stock held by the selling stockholder or issuable upon conversion of shares of our Series A Convertible Preferred Stock, $0.08 par value per share, or our Series A Preferred Stock, held by the selling stockholder. The selling stockholder may sell any, all or none of the securities offered by this prospectus, and we do not know when or in what amount the selling stockholder may sell its shares of common stock hereunder following the effective date of this registration statement. We will not receive any proceeds from the resale of shares of our common stock by the selling stockholder.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>This prospectus provides a general description of the shares of common stock that we and the selling stockholder may offer. Each time we sell shares of our common stock, we will provide the specific terms of the offering in a prospectus supplement. To the extent that the selling stockholder resells any securities, the selling stockholder may be required to provide you with a prospectus supplement containing specific information about the selling stockholder and the specific terms of the offering.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>Any prospectus supplement that we or the selling stockholder provide to you may add, update or change information in this prospectus. You should read this prospectus and any prospectus supplement, as well as the documents incorporated by reference herein and therein, carefully before you invest in any securities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'><b>This prospectus may not be used to consummate a sale of our common stock unless accompanied by a prospectus supplement. </b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>Our common stock is traded on the NASDAQ Capital Market under the symbol &#147;BMRA.&#148; On July 17, 2020, the last reported sale price of our common stock was $10.96 per share.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection2'>We may sell shares of our common stock directly to investors, through agents designated from time to time or to or through underwriters or dealers, on a continuous or delayed basis. For additional information on the methods of sale, you should refer to the section entitled &#147;Plan of Distribution&#148; in this prospectus. If any agents or underwriters are involved in the sale of any shares of our common stock with respect to which this prospectus is being delivered, the names of such agents or underwriters and any applicable fees, commissions, discounts or over-allotment options will be set forth in a prospectus supplement. The price to the public of such shares and the net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement.</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'><b><font style="TEXT-TRANSFORM:uppercase; COLOR:black">Investing in our common stock involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#147;Risk Factors&#148; BEGINNING ON PAGE 5 OF THIS PROSPECTUS, contained in ANY applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus. </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'><b><font style=COLOR:black>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</font></b><font style=COLOR:black>&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><font style=COLOR:black>The date of this prospectus is&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020.</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=PAGE-BREAK-BEFORE:always></font> <div style=page:WordSection3> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>TABLE OF CONTENTS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><b><font style=COLOR:black>Page</font></b></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>ABOUT THIS PROSPECTUS</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>ABOUT THE COMPANY</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>RISK FACTORS</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>USE OF PROCEEDS</font></p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>DESCRIPTION OF CAPITAL STOCK</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>7</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>SELLING STOCKHOLDERS</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>10</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>PLAN OF DISTRIBUTION </font></p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>12</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>LEGAL MATTERS</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>14</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>EXPERTS</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>14</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=566 style="HEIGHT:15.45pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</p></td> <td width=46 style="HEIGHT:15.45pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>15</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=566 style="HEIGHT:12.4pt; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=46 style="HEIGHT:12.4pt; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:0.25in> <td width=566 style="HEIGHT:0.25in; WIDTH:424.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>WHERE YOU CAN FIND MORE INFORMATION</p></td> <td width=46 style="HEIGHT:0.25in; WIDTH:34.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>16</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>0</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric'><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>ABOUT THIS PROSPECTUS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#147;SEC&#148;) using a &#147;shelf&#148; registration process. Under this shelf registration process, we may sell shares of our common stock in one or more offerings up to a total aggregate offering price of $90,000,000. This prospectus also relates to the offer and resale of up to an aggregate of 571,429 shares of our common stock held by the selling stockholder or issuable upon conversion of shares of our Series A Preferred Stock, held by the selling stockholder.&nbsp; The selling stockholder is identified in this prospectus under the heading &#147;Selling Stockholders&#148;. This prospectus provides you with a general description of our common stock that we and the selling stockholder may offer.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>All references to &#147;Company&#148; &#147;we,&#148; &#147;our&#148; or &#147;us&#148; refer solely to Biomerica, Inc.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Each time we sell shares of our common stock, we will provide the specific terms of the offering in a prospectus supplement. To the extent that the selling stockholder resells any shares of our common stock, the selling stockholder may be required to provide you with a prospectus supplement containing specific information about the selling stockholder and the specific terms of the offering. Any prospectus supplement that we or the selling stockholder provide to you may add, update or change information in this prospectus. To the extent there is a conflict between the information contained in this prospectus and any accompanying prospectus supplement, you should rely on the information in the prospectus supplement. This prospectus, together with any accompanying prospectus supplement, includes all material information relating to an offering pursuant to this registration statement. You should read this prospectus, any applicable prospectus supplement and any related free writing prospectus, together with the information incorporated herein by reference as described under the heading &#147;Incorporation of Certain Information by Reference,&#148; before investing in our common stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Neither we, nor any agent, underwriter, dealer, salesperson or other person has authorized any person to give any information or to make any representations other than those contained or incorporated by reference in this prospectus, any accompanying prospectus supplement or any related free writing prospectus in connection with the offer made by this prospectus, any accompanying prospectus supplement or any related free writing prospectus. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or any accompanying prospectus supplement as if we had authorized it. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>This prospectus, any accompanying prospectus supplement or any related <font style=BACKGROUND:white>free writing prospectus</font> do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does this prospectus, any accompanying prospectus supplement or any related free writing prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>You should not assume that the information contained in this prospectus, any accompanying prospectus supplement or any related free writing prospectus is correct on any date after their respective dates or that any information we have incorporated by reference is correct on any date after the date of the document incorporated by reference, even though this prospectus, any accompanying prospectus supplement or any related free writing prospectus may be delivered or securities may be sold on a later date.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Investing in our securities involves a high degree of risk. You should carefully consider the section entitled &#147;Risk Factors&#148; in this prospectus, any accompanying prospectus supplement and any related free writing prospectus before you invest in our securities. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>You should also carefully read the additional information described in the sections entitled &#147;Incorporation of Certain Documents by Reference&#148; and &#147;Where You Can Find More Information&#148; before you invest in our securities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>1</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>This prospectus, any accompanying prospectus supplement, and the documents we incorporate by reference in this prospectus and any accompanying prospectus supplement, contains forward-looking statements within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties. These forward-looking statements are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. We have attempted to identify forward-looking statements by using words such as &#147;may,&#148; &#147;believe,&#148; &#147;will,&#148; &#147;could,&#148; &#147;project,&#148; &#147;anticipate,&#148; &#147;expect,&#148; &#147;estimate,&#148; &#147;should,&#148; &#147;continue,&#148; &#147;potential,&#148; &#147;plan,&#148; &#147;forecasts,&#148; &#147;goal,&#148; &#147;seek,&#148; &#147;intend,&#148; other forms of these words or similar words or expressions or the negative thereof. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We have based our forward-looking statements on our expectations and projections about trends affecting our business and industry and other future events. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Forward-looking statements are subject to substantial risks and uncertainties that could cause our future business, financial condition, results of operations or performance, to differ materially from our historical results or those expressed or implied in any forward-looking statement. Some of the risks and uncertainties that may cause actual results to differ from those expressed or implied in the forward-looking statements are described in the section entitled &#147;Risk Factors&#148; in this prospectus and in any accompanying prospectus supplement, as well as in our other filings with the SEC. In addition, actual results may differ as a result of additional risks and uncertainties of which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>You should read this prospectus in its entirety, together with any accompanying prospectus supplement, the documents that we file as exhibits to the registration statement of which this prospectus is a part, and the documents that we incorporate by reference into this prospectus and any accompanying prospectus supplement, with the understanding that our future results may be materially different from what we currently expect. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of the NASDAQ Stock Market. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We qualify all of our forward-looking statements by these cautionary statements.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>2</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>ABOUT THE COMPANY</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'><i><font style=COLOR:black>The following is a summary of what we believe to be the most important aspects of our business.&nbsp; Please read the additional information in the sections entitled &#147;Incorporation of Certain Documents by Reference&#148; and &#147;Where You Can Find More Information.&#148;</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Our Company</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We are a global medical device company that develops, patents, manufactures and/or markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Our diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in extremely small concentrations.&nbsp; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our primarily focus is on gastrointestinal, food intolerance and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development. In response to the COVID-19 pandemic, we have lunched various serology tests that look for the presence of antibodies to the novel Coronavirus (SARS-CoV-2).&nbsp; The antibodies detected by serology tests can indicate that a person has had an immune response to the SARS-CoV-2, whether symptoms developed from infection or the infection was asymptomatic.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our InFoods&#174; IBS product which is currently in clinical trials in the US, is designed to allow physicians to identify patient specific foods (e.g. eggs, broccoli, wheat, potatoes, corn, etc.), that when removed from the diet, may alleviate or improve an individual's IBS symptoms including, but not limited to, constipation, diarrhea, bloating, pain and indigestion. The InFoods IBS product is a patented diagnostic-guided therapy and is being tested to allow for a patient specific, guided dietary regimen to improve Irritable Bowel Syndrome (IBS) outcomes. An estimated 45 million people in America currently suffer from IBS making it a leading cause for patient doctor visits.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We primarily focus on products for gastrointestinal diseases, food intolerances, diabetes and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Our products are CE marked and/or sold for diagnostic or treatment use around the world where they are registered by each country&#146;s regulatory agency.&nbsp; In addition, some products are cleared for sale in the U.S. by the U.S.&nbsp;Food and Drug Administration, or FDA.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We maintain our headquarters in Irvine, California where we house administration, product development, sales and marketing, customer services and some manufacturing operations. &nbsp;A part of our manufacturing and assembly operations is located in Mexicali, Mexico, in order to reduce the cost of manufacturing and compete more effectively worldwide. &nbsp;We have established wholly owned subsidiaries in both Mexico and Germany. We expend considerable funds in research and development of certain new products that diagnose and, in certain cases, are designed to be used as a therapy for several major medical diseases.&nbsp; These products are both internally developed and licensed from others. We utilize experienced technical personnel to improve existing products, develop new products and evaluate and license or purchase technologies owned by third parties that could be implemented into products we sell.&nbsp; We are currently pursuing the development of multiple tests for the gastrointestinal market, and other disease states that pertain to a patient&#146;s food intolerance, as well as several diagnostic tests that identify persons that have been infected with the COVID-19 virus.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black>Corporate Information</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We were originally incorporated in Delaware in September 1971 as Nuclear Medical Systems, Inc. We also have two wholly owned subsidiaries, Biomerica de Mexico, and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets. Our principal executive offices are located at 17571 Von Karman Avenue, Irvine, California 92614, and our telephone number is (949) 645-2111. Our corporate website address is www.biomerica.com. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>3</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black>Implications of Being a Smaller Reporting Company</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We are a <font style=BACKGROUND:white>&#147;smaller reporting company&#148;</font> as defined in the Securities Exchange Act of 1934, or the Exchange Act, and have elected to take advantage of certain of the scaled disclosures available to smaller reporting companies.<b> </b></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>4</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>RISK FACTORS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks described in (i) the sections entitled &#147;Risk Factors&#148; in our most recent Annual Report on Form 10-K and subsequent quarterly, annual and other reports, each as filed with the SEC, which are incorporated by reference in this prospectus in their entirety and (ii) any amendment or updates to our risk factors reflected in subsequent filings with the SEC, including in any applicable prospectus supplement or related free writing prospectus. For more information, see the sections entitled &#147;Incorporation of Certain Documents by Reference&#148; and &#147;Where You Can Find More Information.&#148; Our business, financial condition or results of operations could be materially adversely affected by any of these risks. In addition, the trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, financial condition or results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>This prospectus and the documents we incorporate by reference in this prospectus contain forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks described in this prospectus and in the documents incorporated by reference in this prospectus. For more information, see &#147;Special Note Regarding Forward-Looking Information.&#148;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black lang=EN-IN>5</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>USE OF PROCEEDS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We will retain broad discretion over the use of the net proceeds from the sale of our common stock offered by us hereby. Except as described in any prospectus supplement or any related free writing prospectus that we may authorize to be provided to you, we currently intend to use the net proceeds from the sale of our common stock offered hereby for working capital and general corporate purposes, which may include capital expenditures, debt repayment, research and development, sales and marketing and general and administrative expenses. We may also use a portion of the net proceeds to acquire or invest in businesses, products and technologies that are complementary to our own, although we have no current plans, commitments or agreements with respect to any such acquisitions or investments as of the date of this prospectus. We will set forth in the applicable prospectus supplement or free writing prospectus our intended use for the net proceeds received from the sale of any common stock sold pursuant to the prospectus supplement or free writing prospectus.&nbsp; Our management will have broad discretion in the allocation of the net proceeds from this offering.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Pending the application of the net proceeds, we may invest the net proceeds in short-term, investment grade, interest-bearing securities, certificates of deposit or direct or guaranteed obligations of the U.S. government. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We will not receive any proceeds from the sale of shares of our common stock by the selling stockholder. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>6</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>DESCRIPTION OF CAPITAL STOCK</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The following is a summary of all material characteristics of our capital stock as set forth in our First Amended and Restated Certificate of Incorporation, Bylaws and our Series A Certificate of Designation, as corrected, the Certificate of Designation. The summary does not purport to be complete and is qualified in its entirety by reference to our First Amended and Restated Certificate of Incorporation, Bylaws, and Certificate of Designation, copies of which have been filed as exhibits to the registration statement of which this prospectus is a part. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Common Stock</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We may issue shares of our common stock from time to time. We are authorized to issue 25,000,000 shares of common stock, par value $0.08 per share. As of July 17, 2020, there were 11,752,589 shares of common stock issued and outstanding. The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. The holders of common stock are not entitled to cumulative voting rights with respect to the election of directors, and as a consequence, minority stockholders will not be able to elect directors on the basis of their votes alone. Subject to preferences that may be applicable to any shares of preferred stock issued in the future, holders of common stock are entitled to receive dividends on a pro rata basis as may be declared by our board out of funds legally available therefor. In the event of a liquidation, dissolution or winding up of our Company, holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of common stock are, and all shares of common stock to be outstanding upon completion of this offering will be, fully paid and nonassessable.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Anti-Takeover Effects of Provisions of Our First Amended and Restated Certificate of Incorporation, Bylaws and Delaware Law </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We are subject to the provisions of Section 203 of the Delaware General Corporation Law. Section 203 prohibits a publicly-held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a period of three years after the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#147;business combination&#148; includes mergers, asset sales and other transactions resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an &#147;interested stockholder&#148; is a person who, together with affiliates and associates, owns, or within the prior three years did own, 15% or more of the corporation&#146;s voting stock.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our First Amended and Restated Certificate of Incorporation and Bylaws, among other things, prohibit cumulative voting in the election of directors. The First Amended and Restated Certificate of Incorporation authorizes the board of directors to issue up to 5,000,000 shares of preferred stock and to determine the rights, preferences and privileges of these shares of preferred stock without any further vote or action by the stockholders, and specifies that the authorized number of directors may be changed only by a resolution of the board of directors. Special meetings of the stockholders may be called only by the board of directors, the chairman of the board of directors or the President or Secretary. The provisions described above could have the effect of making it more difficult for a third-party to acquire a majority of our outstanding voting stock, or delay, prevent or deter a merger, acquisition or tender offer in which our stockholders could receive a premium for their shares, a proxy contest or other change in our management.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b>Preferred Stock</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Pursuant to the terms of our First Amended and Restated Certificate of Incorporation, our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue up to 5,000,000 shares of preferred stock, par value $0.08 per share, in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further action by our stockholders. Our board of directors also can increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control or the removal of management and could adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock.&nbsp; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>7</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b>Series A Preferred Stock</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>On February 4, 2020, we filed a Certificate of Designations, Preferences and Rights of Series A 5% Convertible Preferred Stock with the Secretary of State of the State of Delaware, which designated 571,429 of our preferred stock as Series A Preferred Stock with the powers, preferences and rights set forth therein. As of July 17, 2020, there were 321,429 shares of Series A Preferred Stock issued and outstanding.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i>Voting Rights. </i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Except as otherwise provided by Delaware law, other applicable law or as provided in the Certificate of Designations, the holders of our Series A Preferred Stock are not entitled to vote on any matter submitted for a vote of holders of our common stock. The consent of the holders of at least a majority of the outstanding shares of our Series A Preferred Stock will be required to, among other matters, (i) alter, amend or change adversely any rights, preferences, or privileges of our Series A Preferred Stock, (ii) amend <font style=COLOR:black>our First Amended and Restated Certificate of Incorporation or Bylaws in any manner that would impair or reduce the rights of our Series A Preferred Stock, or (iii) amend, alter, or repeal any provision of the Certificate of Designations</font>. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i>Dividends. </i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Shares of our Series A Preferred Stock accrue annual preferred dividends at a rate of $0.175 per share, which are payable when, as and if declared by our board of directors. The holders of the outstanding shares of our Series A Preferred Stock are also entitled to receive on each share of our Series A Preferred Stock dividends prior to, or simultaneously with, any dividend declared with respect to our common stock equal to the greater of (i) the amount of dividends that have accrued on such share of our Series A Preferred Stock and (ii) the dividend payable with respect to each share of our common stock issuable upon conversion of such share of our Series A Preferred Stock.&nbsp; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i>Liquidation Preference. </i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In the event of a liquidation, dissolution or winding up of the Company, or a Deemed Liquidation Event (as defined in the Certificate of Designation) the holders of our Series A Preferred Stock are eligible to receive the greater of (i) an amount equal to $3.50 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination, or other similar recapitalization with respect to our Series A Preferred Stock) (the &#147;Original Issue Price&#148;), plus an amount equal to accrued and unpaid dividends thereon, or (ii) such amount per share as would have been payable had all shares of our Series A Preferred Stock been converted into our common stock immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i>Conversion. </i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Shares of our Series A Preferred Stock are convertible at the option of the holder at any time into shares of our common stock at a conversion rate determined by dividing the Original Issue Price by $3.50 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination, recapitalizations, dividends, distributions and certain issuances of common stock) (the &#147;Conversion Price&#148;). This formula initially results in a one-to-one conversion ratio. The Conversion Price is subject to customary weighted average anti-dilution adjustments in the event of certain dilutive issuances of shares of our common stock or convertible securities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We may require the conversion of all of the outstanding shares of our Series A Preferred Stock if the closing sale price of our common stock equals or exceeds $9.00 for a period of five (5) consecutive trading days with a minimum average trading volume of 35,000 shares per day over such period&#894; provided, that, on such date, the shares of our common stock issuable upon conversion of our Series A Preferred Stock are registered for resale under the Securities Act or are otherwise eligible for resale pursuant to Rule 144 thereunder.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>8</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Notwithstanding the foregoing, prior to the receipt of all approvals, if any, of the shareholders of the Company necessary for purposes of the rules and regulations of the applicable Trading Market (as defined in the Stock Purchase Agreement), our Series A Preferred Shares shall not be converted into shares of Common Stock: (i) in the aggregate into more than 19.99% of the shares of Common Stock outstanding immediately prior to the Issuance Date, subject to appropriate adjustment in the event of a stock split, stock dividend, combination or other similar recapitalization, or (ii) by any beneficial holder (as such term is defined under Rule 13d-3 of the Exchange Act) or &#147;group&#148; (as such term is defined under Rule 13d-5 of the Exchange Act) (such beneficial holder or group, a &#147;Capped Holder&#148;), if (A) the aggregate number of shares of Common Stock issued to such Capped Holder upon such conversion and any Conversion Shares then held by the Capped Holders, plus (B) the number of shares of Common Stock underlying our Series A Preferred Shares that would be held at such time by the Capped Holders (after giving effect to such conversion), plus (C) the aggregate number of shares of Common Stock held by such Capped Holder as of immediately prior to the Issuance Date, would in the aggregate exceed more than 19.99% of the shares of Common Stock outstanding immediately prior to the Issuance Date (without regard to any limitation on conversion pursuant to this Section 5(n)), then such Capped Holder shall be entitled to convert such number of our Series A Preferred Shares as would result in the sum of clauses (A), (B) and (C) (after giving effect to such conversion) being equal to 19.99% of the shares of Common Stock outstanding immediately prior to the Issuance Date, in each case, subject to appropriate adjustment in the event of a stock split, stock dividend, combination or other similar recapitalization. Any Series A Preferred Shares which a holder has elected to convert but which, by reason of the previous sentence are not so converted, shall be treated as if the holder had not made such election to convert and such Series A Preferred Shares shall remain outstanding.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i>Ranking. </i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our Series A Preferred Stock ranks senior to our common stock with respect to distributions upon any liquidation, on parity to any class or series of our capital stock hereafter created specifically ranking by its terms on parity with our Series A Preferred Stock and junior to any class or series of our capital stock hereafter created specifically ranking by its terms senior to our Series A Preferred Stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>NASDAQ Capital Market Listing</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our common stock is listed on the NASDAQ Capital Market and traded under the symbol &#147;BMRA.&#148; On July 17, 2020, the last reported sale price for our common stock on the NASDAQ Capital Market was $10.96 per share.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Transfer Agent and Registrar</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The transfer agent and registrar for the common stock is Issuer Direct. The transfer agent and registrar&#146;s address is 1981 East 4800 So, Suite 100, Salt Lake City, Utah 84117.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:6pt 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>9</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:6pt 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:6pt 0in 0pt; TEXT-AUTOSPACE:' align=center><b>SELLING STOCKHOLDERS</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>This prospectus relates to the offer and resale of up to an aggregate of 571,429 shares of our common stock from time to time by the stockholder identified in the table below, which we refer to in this prospectus as the selling stockholder. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The shares of our common stock being offered by the selling stockholder include shares of our common stock that were issued and are issuable upon conversion of the shares of our Series A Preferred Stock issued to the selling stockholder. For additional information regarding the issuance of the shares of our Series A Preferred Stock and the shares of our common stock issued and issuable upon conversion thereof, see &#147;Stock Purchase Agreement with Selling Stockholder&#148; below.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The table sets forth certain information with respect to the selling stockholder, including (i) the identity of the selling stockholder, (ii) the number of shares of our common stock beneficially owned by the selling stockholder before this offering, (iii) the number of shares of our common stock being offered by the selling stockholder in this offering, and (iv) the number and percentage of shares of our common stock beneficially owned by the selling stockholder upon completion of this offering, assuming that all of the shares being offered by this prospectus are sold. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The information in the table and accompanying footnotes is based on information made available to us by the selling stockholder. Under applicable SEC rules, beneficial ownership includes any shares of our common stock as to which a person has sole or shared voting power or investment power, and any shares of our common stock which the person has the right to acquire within 60 days of July 17, 2020 through the exercise of any option, warrant or right, or through the conversion of any convertible security. The percentage of shares beneficially owned is based on 11,752,589 shares of common stock issued and outstanding as of July 17, 2020. Unless otherwise indicated in the footnotes to the table, and subject to community property laws where applicable, we believe that the selling stockholder named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=100% bordercolor=transparent style="WIDTH:100%; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.25pt" cellpadding=0 cellspacing=0> <tr style=PAGE-BREAK-INSIDE:avoid> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BACKGROUND:#eeeeee; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.5pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; BORDER-LEFT:0px; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Selling Stockholder</font></b></p></td> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BACKGROUND:#eeeeee; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.5pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; BORDER-LEFT:0px; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Shares of Common Stock Beneficially Owned Before This Offering (1)</font></b></p></td> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BACKGROUND:#eeeeee; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.5pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; BORDER-LEFT:0px; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Shares of Common Stock Being Offered in This Offering</font></b></p></td> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BACKGROUND:#eeeeee; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.5pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; BORDER-LEFT:0px; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Shares of Common Stock Beneficially Owned upon Completion of This Offering (2)</font></b></p></td> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BACKGROUND:#eeeeee; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.5pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; BORDER-LEFT:0px; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="BACKGROUND:white; COLOR:black">Percentage of Shares Beneficially Owned upon Completion of This Offering </font></b></p></td> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:1.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=28% style="WIDTH:28%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Palm Global Small Cap Master Fund LP</font></p></td> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=15% style="WIDTH:15%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>571,429</font></p></td> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=15% style="WIDTH:15%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>571,429</font></p></td> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=15% style="WIDTH:15%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td width=15% style="WIDTH:15%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="BACKGROUND:white; COLOR:black">* </font></p></td> <td width=1% style="WIDTH:1%; BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:white; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /> <td style="BACKGROUND:#eeeeee; PADDING-BOTTOM:0.25pt; PADDING-TOP:0.25pt; PADDING-LEFT:0.25pt; PADDING-RIGHT:0.25pt" valign=bottom /></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><br>* <font style=BACKGROUND:white>Represents beneficial ownership of</font> less than 1% of our outstanding shares. </p> <table width=100% bordercolor=transparent style=WIDTH:100% cellpadding=0 cellspacing=0> <tr style=PAGE-BREAK-INSIDE:avoid> <td style="WIDTH:0.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top /> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>(1)</font></p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Consists of (i) 250,000 shares of common stock and (ii) 321,429 shares of Series A Preferred Stock convertible into 321,429 shares of common stock. </font></p></td></tr> <tr style=PAGE-BREAK-INSIDE:avoid> <td style="WIDTH:0in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top /> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>(2)</font></p></td> <td style="PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Assumes that all shares of common stock being registered on behalf of the selling stockholder under the registration statement of which this prospectus forms a part are sold in this offering, and that the selling stockholder will not acquire additional shares of our common stock after the date of this prospectus and prior to completion of this offering. </font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>All of the shares being registered for resale by the selling stockholder pursuant to this prospectus were issued and outstanding prior to the original date of filing of the registration statement of which this prospectus is a part.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The registration of the shares of our common stock set forth in the table does not mean that the selling stockholder will sell or otherwise dispose of all or any of those securities. The selling stockholder may sell any, all or none of the securities offered by this prospectus, and we do not know when or in what amount the selling stockholder may sell its shares of common stock hereunder following the effective date of this registration statement. Information concerning the selling stockholder may change from time to time and, if necessary, we will amend or supplement this prospectus as required by SEC rules.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>10</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u>Stock Purchase Agreement with Selling Stockholder</u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u></u></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>On February 21, 2020, we entered into a Stock Purchase Agreement (the &#147;Stock Purchase Agreement&#148;) with, and consummated a private placement of 571,429 shares of our Series A Preferred Stock to the selling stockholder. The offer and sale of the shares were not registered under the Securities Act in reliance on the exemption afforded by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In connection with the Stock Purchase Agreement, we entered into a registration rights agreement (the &#147;Registration Rights Agreement&#148;) with the selling stockholder, pursuant to which we agreed to file a registration statement registering the resale of the shares of our common stock issuable upon conversion of our Series A Preferred Stock issued to the selling stockholder under the Stock Purchase Agreement. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>As of July 17, 2020, the selling stockholder holds 321,429 shares of our Series A Preferred Stock and has converted the other 250,000 shares of our Series A Preferred Stock purchased under the Stock Purchase Agreement into shares of our common stock. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><u>Board Observer Agreement</u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In connection with the Stock Purchase Agreement, we entered into a board observer agreement (the &#147;Board Observer Agreement&#148;) with the selling stockholder. The Board Observer Agreement provides that for the longer of three years following the closing of the transactions under the Stock Purchase Agreement or for so long as the selling stockholder holds any shares of our Series A Preferred Stock, the selling stockholder will have the right to appoint one individual to attend and observe meetings of our board of directors, subject to certain exceptions.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><u>No Material Relationships</u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Except as described above, there are no material relationships between us and the selling stockholder, and there have been no material relationships within the past three years. In addition, we have been advised that the selling stockholder is not, nor is it affiliated with, any broker-dealer or underwriter.</p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=PAGE-BREAK-BEFORE:always></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>11</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>PLAN OF DISTRIBUTION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We or the selling stockholder may sell shares of our common stock from time to time pursuant to underwritten public offerings, negotiated transactions, block trades or a combination of these methods. We or the selling stockholder may sell shares of our common stock to or through underwriters or dealers, through agents, or directly to one or more purchasers. We or the selling stockholder may sell shares of our common stock from time to time in one or more transactions: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>at a fixed price or prices, which may be changed; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>at market prices prevailing at the time of sale; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>at prices related to such prevailing market prices; or </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>at negotiated prices. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We or the selling stockholder may also sell shares of our common stock covered by this registration statement in an &#147;at the market offering&#148; as defined in Rule 415 under the Securities Act. Such offering may be made into an existing trading market for such securities in transactions at other than a fixed price, either: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>on or through the facilities of the NASDAQ Capital Market or any other stock exchange or quotation or trading service on which our common stock may be listed, quoted or traded at the time of sale; and/or </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>to or through a market maker other than on the NASDAQ Capital Market or such other stock exchanges or quotation or trading services. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Such at-the-market offerings, if any, may be conducted by underwriters acting as principal or agent. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of our common stock, including, to the extent applicable: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>whether we and/or the selling stockholder will be selling shares of our common stock thereunder;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>the name or names of any underwriters, dealers or agents, if any; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>the purchase price of the common stock and the proceeds we or the selling stockholder will receive from the sale; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>any over-allotment options under which underwriters may purchase additional common stock from us or the selling stockholder; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>any agency fees or underwriting discounts and other items constituting agents&#146; or underwriters&#146; compensation; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>any public offering price; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>any discounts or concessions allowed or reallowed or paid to dealers; and </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.75in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>any securities exchange or market on which our common stock may be listed. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Only underwriters named in the prospectus supplement are underwriters of the common stock offered by the prospectus supplement. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>If underwriters are used in the sale, they will acquire the common stock for their own account and may resell the common stock from time to time in one or more transactions at a fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase the common stock will be subject to the conditions set forth in the applicable underwriting agreement. We or the selling stockholder may offer our common stock to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions unless otherwise specified in the prospectus supplement, the underwriters will be obligated to purchase all of the common stock offered by the prospectus supplement. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may change from time to time. We or the selling stockholder may use underwriters with whom we or the selling stockholder have a material relationship. We will describe in the prospectus supplement, naming the underwriter, the nature of any such relationship. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>12</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We or the selling stockholder may sell our common stock directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of our common stock, and we will describe any commissions we or the selling stockholder will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best-efforts basis for the period of its appointment. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We or the selling stockholder may authorize agents or underwriters to solicit offers by certain types of institutional investors to purchase common stock from us or the selling stockholder at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the commissions we or the selling stockholder must pay for solicitation of these contracts in the prospectus supplement. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We or the selling stockholder may provide agents and underwriters with indemnification against civil liabilities related to any offering pursuant to this prospectus, including liabilities under the Securities Act, or contribution with respect to payments that the agents or underwriters may make with respect to these liabilities. Agents and underwriters may engage in transactions with, or perform services for, us or the selling stockholder in the ordinary course of business. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Any underwriter may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. Overallotment involves sales in excess of the offering size, which create a short position. This short sales position may involve either &#147;covered&#148; short sales or &#147;naked&#148; short sales. Covered short sales are short sales made in an amount not greater than the underwriters&#146; over-allotment option to purchase additional shares in the offering. The underwriters may close out any covered short position either by exercising their over-allotment option or by purchasing shares of our common stock in the open market. To determine how they will close the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market, as compared to the price at which they may purchase shares through the over-allotment option. Naked short sales are short sales in excess of the over-allotment option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that, in the open market after pricing, there may be downward pressure on the price of the shares that could adversely affect investors who purchase shares in the offering. Stabilizing transactions permit bids to purchase the underlying security for the purpose of fixing the price of the security so long as the stabilizing bids do not exceed a specified maximum. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a covering transaction to cover short positions. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Any underwriters who are qualified market makers on the </font>NASDAQ Capital Market<font style=COLOR:black>, or any other stock exchange or which our common stock may be listed at the time of sale, may engage in passive market making transactions in our common stock on the </font>NASDAQ Capital Market<font style=COLOR:black> or such other stock exchange in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the shares of our common stock. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for our common stock; if all independent bids are lowered below the passive market maker&#146;s bid, however, the passive market maker&#146;s bid must then be lowered when certain purchase limits are exceeded. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Similar to other purchase transactions, an underwriter&#146;s purchase to cover the syndicate short sales or to stabilize the market price of our common stock may have the effect of raising or maintaining the market price of our common stock or preventing or mitigating a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of the common stock if it discourages resales of the shares.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Neither we nor the underwriters makes any representation or prediction as to the effect that the transactions described above may have on the price of the common stock offered by this prospectus. If such transactions are commenced, they may be discontinued without notice at any time.&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black lang=EN-IN>13</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:12pt; COLOR:black; LINE-HEIGHT:115%" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>LEGAL MATTERS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Certain legal matters, including the validity of the issuance of the shares of common stock offered by this prospectus will be passed upon for us by</font> <font style=COLOR:black>Stradling Yocca Carlson &amp; Rauth, P.C., Newport Beach, California. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>EXPERTS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>PKF, LLP, an independent registered public accounting firm, has audited the consolidated financial statements of Biomerica, Inc. and Subsidiaries included in our Annual Report on Form 10-K, for the years ended May 31, 2018 and 2019 as set forth in their report on our consolidated financial statements, which is incorporated by reference in this prospectus and elsewhere in this registration statement. Such consolidated financial statements of Biomerica, Inc. and Subsidiaries are incorporated by reference in reliance on PKF, LLP&#146;s reports, given on the authority of such firm as experts in accounting and auditing.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>14</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The SEC allows us to &#147;incorporate&#148; into this prospectus information that we file with the SEC in other documents. This means that we can disclose important information to you by referring to other documents that contain that information. Any information that we incorporate by reference into this prospectus is considered part of this prospectus.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>&nbsp;Information contained in this prospectus and information that we file with the SEC in the future and incorporate by reference in this prospectus automatically modifies and supersedes previously filed information, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. Any information so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>&nbsp;The following documents previously filed by us with the SEC are incorporated in this prospectus by reference:</font></p> <ul type=disc style="MARGIN-BOTTOM:0in; MARGIN-TOP:0in"> <li style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'><a name=_Aci_Pa19_2D31387C3336>Our Annual Report on Form&nbsp;10-K for the fiscal year ended May, 31, 2019, as filed with the SEC on August 29, 2019;&nbsp;</a> <li style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'><a name=_Aci_Pa20_2D31387C3336>Our Definitive Proxy Statement on Schedule&nbsp;14A, as filed with the SEC on September 24,&nbsp;2019 (to the extent incorporated by reference into Part&nbsp;III of our Annual Report on Form 10-K for the fiscal year ended May, 31, 2019);</a> <li style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'><a name=_Aci_Pa21_2D31387C3336>Our Quarterly Reports on Form&nbsp;10-Q for the fiscal quarters ended August&nbsp;31,&nbsp;2019, November 30, 2019, and February 29, 2020, as filed with the SEC on October 15,&nbsp;2019, January 14, 2020 and April 14, 2020, respectively;&nbsp;</a> <li style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:ideograph-numeric'><a name=_Aci_Pa22_2D31387C3336>Our Current Reports on Form&nbsp;8-K as filed with the SEC on each of September 4, 2019, December 13, 2019, February 27, 2020, March 18, 2020, March 20, 2020, April 6, 2020, May 11, 2020, June 2, 2020, June 17, 2020, and June 30, 2020; and</a> </li></ul> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><a name=_Aci_Pa23_2D31387C3336><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>The description of our common stock contained in our registration statement on Form&nbsp;8-A, filed with the SEC on August 23, 2016, including any amendment or report filed for the purpose of updating such description</font>.</a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We also incorporate by reference all documents (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date the initial registration statement is initially filed and prior to the termination of this offering, provided that nothing in this prospectus shall be deemed to incorporate portions of documents or information &#147;furnished&#148; and not &#147;filed&#148; with the SEC.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>You should rely only on the information incorporated by reference or provided in this prospectus or any accompanying prospectus supplement. We have not authorized anyone to provide you with different information. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>You should not assume that the information contained in this prospectus and any accompanying prospectus supplement is correct on any date after their respective dates, even though this prospectus or any prospectus supplement is delivered or securities are sold on a later date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We will provide to each person, including any beneficial owner, to whom a prospectus is delivered, upon oral or written request, a copy of any document incorporated by reference at no cost. Requests should be made to:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Zackary Irani</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Chairman &amp; Chief Executive Officer</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Biomerica, Inc.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>17571 Von Karman Avenue Irvine, California 92614</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(949) 645-2111</font></p></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=PAGE-BREAK-BEFORE:always></font> <div style=page:WordSection4> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>15</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>WHERE YOU CAN FIND MORE INFORMATION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public at no cost from the SEC&#146;s website at </font><font style="TEXT-DECORATION:none; COLOR:black">http://www.sec.gov</font><font style=COLOR:black>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>This prospectus constitutes a part of a registration statement on Form S-3 filed under the Securities Act. As permitted by the SEC&#146;s rules, this prospectus and any accompanying prospectus supplement, which form a part of the registration statement, do not contain all the information that is included in the registration statement. You will find additional information about us in the registration statement. Any statements made in this prospectus or any prospectus supplement concerning legal documents are not necessarily complete and you should read the documents that are filed as exhibits to the registration statement or otherwise filed with the SEC for a more complete understanding of the document or matter.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black lang=EN-IN>16</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">$90,000,000</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center>&nbsp;</p> <p style=page:WordSection5 align=center><img width=3439 height=553 style="HEIGHT:51px; WIDTH:244px" src=logo.jpg></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">BIOMERICA, INC.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">Common Stock</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">571,429 Shares of Common Stock </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b><font style="FONT-SIZE:12pt; COLOR:black">Offered by the Selling Stockholder</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5' align=center><b><font style=COLOR:black>PROSPECTUS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection5'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; page:WordSection5' align=center><b><font style=COLOR:black>, 2020</font></b></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=PAGE-BREAK-BEFORE:always></font></b> <div style=page:WordSection6> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>PART II</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>INFORMATION NOT REQUIRED IN PROSPECTUS</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM&nbsp;14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'><font style=COLOR:black>The expenses in connection with the issuance and distribution of the securities being registered, other than underwriting discounts and commissions, are estimated below:</font></p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.45pt> <td width=402 style="HEIGHT:15.45pt; WIDTH:301.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 4.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>SEC registration fee................................................................................................ </font></p></td> <td width=7 style="HEIGHT:15.45pt; WIDTH:5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=66 style="HEIGHT:15.45pt; WIDTH:49.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>[]</font></p></td> <td width=1 style="HEIGHT:15.45pt; WIDTH:1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=402 style="HEIGHT:15.45pt; WIDTH:301.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 4.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Legal fees and expenses........................................................................................ </font></p></td> <td width=7 style="HEIGHT:15.45pt; WIDTH:5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=66 style="HEIGHT:15.45pt; WIDTH:49.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>[]</font></p></td> <td width=1 style="HEIGHT:15.45pt; WIDTH:1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>*</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=402 style="HEIGHT:15.45pt; WIDTH:301.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 4.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Accounting fees and expenses............................................................................ </font></p></td> <td width=7 style="HEIGHT:15.45pt; WIDTH:5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=66 style="HEIGHT:15.45pt; WIDTH:49.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>[]</font></p></td> <td width=1 style="HEIGHT:15.45pt; WIDTH:1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>*</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=402 style="HEIGHT:15.45pt; WIDTH:301.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 4.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Miscellaneous......................................................................................................... </font></p></td> <td width=7 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=66 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:49.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>[]</font></p></td> <td width=1 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=402 style="HEIGHT:15.45pt; WIDTH:301.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 4.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Total expenses*...................................................................................................... </font></p></td> <td width=7 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:5pt; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=66 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:49.5pt; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>[]</font></p></td> <td width=1 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:1pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 58.5pt 0pt 63pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 58.5pt 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-13.5pt'><font style=COLOR:black>*&nbsp;&nbsp;&nbsp; Does not include expense of preparing prospectus supplements and other expenses relating to specific offerings made pursuant to this prospectus.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 58.5pt 0pt 81pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM&nbsp;15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; INDEMNIFICATION OF DIRECTORS AND OFFICERS.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'><font style=COLOR:black>Our First Amended and Restated Certificate of Incorporation includes a provision that eliminates the personal liability of our directors for monetary damages for breach of their fiduciary duty as a director to the fullest extent permitted under Delaware law. The effect of this provision of our First Amended and Restated Certificate of Incorporation, as permitted by Section 145 of the Delaware General Corporation Law, is to eliminate our rights and those of our stockholders (through stockholders&#146; derivative suits on behalf of our Company) to recover damages against a director or officer for breach of the fiduciary duties as a director or officer (including breaches resulting from negligent or grossly negligent behavior), except under certain situations defined by statute.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'><font style=COLOR:black>In addition, as permitted by Section 145, our Bylaws provide that we are required to indemnify our directors and officers and persons serving in these capacities in other business enterprises (including, for example, our subsidiaries) at our request, to the fullest extent permitted by Delaware law, including in those circumstances in which indemnification would otherwise be discretionary. Our Bylaws also provide that we may, in our discretion, indemnify our employees and agents in circumstances where indemnification is not required by law. The rights conferred in the Bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, executive officers and employees. We may not retroactively amend our bylaw provisions in a way that reduces the protections of the directors, officers and employees who benefit from these provisions.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.25in'><font style=COLOR:black>Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.<br clear=all style=PAGE-BREAK-BEFORE:always></font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM&nbsp;16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXHIBITS.</font></b></p> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr style=HEIGHT:30.95pt> <td width=48 style="BORDER-TOP:0px; HEIGHT:30.95pt; BORDER-RIGHT:0px; WIDTH:0.5in; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Exhibit&nbsp;No.</font></b></p></td> <td width=31 style="HEIGHT:30.95pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'><b></b>&nbsp;</p></td> <td width=545 style="BORDER-TOP:0px; HEIGHT:30.95pt; BORDER-RIGHT:0px; WIDTH:408.7pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Description</font></b></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=48 style="HEIGHT:12.4pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=31 style="HEIGHT:12.4pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:12.4pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:17.55pt> <td width=48 style="HEIGHT:17.55pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1.1</font></p></td> <td width=31 style="HEIGHT:17.55pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:17.55pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Form of Underwriting Agreement*</font></p></td></tr> <tr style=HEIGHT:30.95pt> <td width=48 style="HEIGHT:30.95pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3.1</font></p></td> <td width=31 style="HEIGHT:30.95pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:30.95pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>First Amended and Restated Certificate of Incorporation of the Company (incorporated herein by reference to Exhibit&nbsp;3.8 to the Company&#146;s Annual Report on Form 10-KSB, filed September 13, 2000). </font></p></td></tr> <tr style=HEIGHT:30.95pt> <td width=48 style="HEIGHT:30.95pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3.2</font></p></td> <td width=31 style="HEIGHT:30.95pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:30.95pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Certificate of Correction of the Certificate of Designation for the Series A Convertible Preferred Stock, filed with the Secretary of State of Delaware on February 26, 2020 (incorporated herein by reference to Exhibit&nbsp;3.1 to the Company&#146;s Current Report on Form 8-K, filed February 27, 2020).</font></p></td></tr> <tr style=HEIGHT:30.95pt> <td width=48 style="HEIGHT:30.95pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3.3</font></p></td> <td width=31 style="HEIGHT:30.95pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:30.95pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Bylaws of the Company (incorporated herein by reference to Exhibit 3.2 to Amendment No. 1 to the Company&#146;s Registration Statement on Form S-1/A, filed July 14, 1983.)</font></p></td></tr> <tr style=HEIGHT:30.95pt> <td width=48 style="HEIGHT:30.95pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4.1</font></p></td> <td width=31 style="HEIGHT:30.95pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:30.95pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Form of Common Stock Certificate (incorporated herein by reference to Exhibit 4.1 of the Company&#146;s Registration Statement on Form SB-2, filed September 16, 1999). </font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=48 style="HEIGHT:15.45pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5.1</font></p></td> <td width=31 style="HEIGHT:15.45pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:15.45pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Opinion of Legal Counsel&#177;</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=48 style="HEIGHT:15.45pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>23.1</font></p></td> <td width=31 style="HEIGHT:15.45pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:15.45pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Consent of PKF, LLP&#177;</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=48 style="HEIGHT:15.45pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>23.2</font></p></td> <td width=31 style="HEIGHT:15.45pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:15.45pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Consent of Legal Counsel (included in Exhibit&nbsp;5.1)&#177;</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=48 style="HEIGHT:15.45pt; WIDTH:0.5in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>24.1</font></p></td> <td width=31 style="HEIGHT:15.45pt; WIDTH:23.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=545 style="HEIGHT:15.45pt; WIDTH:408.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Power of Attorney (included on the signature page of this registration statement)&#177;</font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style="BORDER-TOP:#7f0000 1pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&#177;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed herewith.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>* &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To be filed by amendment or as an exhibit to a document to be incorporated by reference herein in connection with an offering of the offered securities, if applicable.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; LINE-HEIGHT:115%'><br clear=all style=PAGE-BREAK-BEFORE:always></font></b> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:12pt; COLOR:black; LINE-HEIGHT:115%" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>ITEM&nbsp;17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UNDERTAKINGS.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>The undersigned registrant hereby undertakes:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 29.7pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(1)&nbsp;&nbsp; To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(i)&nbsp;&nbsp;&nbsp; To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(ii)&nbsp;&nbsp; To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration statement; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(iii)&nbsp; To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>provided, however, that paragraphs (i), (ii) and (iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(2)&nbsp;&nbsp; That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(3)&nbsp;&nbsp; To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(4)&nbsp;&nbsp; That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(i)&nbsp;&nbsp;&nbsp; Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(ii)&nbsp;&nbsp; Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:12pt; COLOR:black" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(5)&nbsp;&nbsp; That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(i)&nbsp;&nbsp;&nbsp; Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(ii)&nbsp;&nbsp; Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(iii)&nbsp; The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(iv)&nbsp; Any other communication that is an offer in the offering made by an undersigned registrant to the purchaser.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(6)&nbsp;&nbsp; That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#146;s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style=COLOR:black>(7)&nbsp;&nbsp; Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.&nbsp;</font></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; LINE-HEIGHT:115%'><br clear=all style=PAGE-BREAK-BEFORE:always></font></b> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:12pt; COLOR:black; LINE-HEIGHT:115%" lang=EN-IN> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>SIGNATURES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.55in'><font style=COLOR:black>Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&nbsp;S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irvine, State of California, on July 20, 2020.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.45pt> <td width=306 style="HEIGHT:15.45pt; WIDTH:229.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=318 colspan=2 style="HEIGHT:15.45pt; WIDTH:238.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>BIOMERICA, INC.</font></b></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=306 style="HEIGHT:12.4pt; WIDTH:229.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=318 colspan=2 style="HEIGHT:12.4pt; WIDTH:238.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=306 style="HEIGHT:15.45pt; WIDTH:229.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=84 style="HEIGHT:15.45pt; WIDTH:63pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>By:</font></p></td> <td width=234 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:175.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Zackary Irani</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=306 style="HEIGHT:15.45pt; WIDTH:229.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=84 style="HEIGHT:15.45pt; WIDTH:63pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=234 style="HEIGHT:15.45pt; WIDTH:175.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Zackary Irani</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=306 style="HEIGHT:15.45pt; WIDTH:229.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=84 style="HEIGHT:15.45pt; WIDTH:63pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=234 style="HEIGHT:15.45pt; WIDTH:175.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chairman and Chief Executive Officer</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=306 style="HEIGHT:12.4pt; WIDTH:229.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=84 style="HEIGHT:12.4pt; WIDTH:63pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=234 style="HEIGHT:12.4pt; WIDTH:175.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Each person whose signature appears below constitutes and appoints Zackary Irani and Janet Moore, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) and supplements to this registration statement&nbsp;(or any other registration statement for the same offering that is effective upon filing pursuant to Rule&nbsp;462(b) under the Securities Act of 1933, as amended) and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact and agents, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.&nbsp;</font></p> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30.95pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:30.95pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Name</font></b></p></td> <td width=18 style="HEIGHT:30.95pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'><b></b>&nbsp;</p></td> <td width=276 style="BORDER-TOP:0px; HEIGHT:30.95pt; BORDER-RIGHT:0px; WIDTH:207pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Title</font></b></p></td> <td width=18 style="HEIGHT:30.95pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'><b></b>&nbsp;</p></td> <td width=168 style="BORDER-TOP:0px; HEIGHT:30.95pt; BORDER-RIGHT:0px; WIDTH:1.75in; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Date</font></b></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="HEIGHT:12.4pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Zackary Irani</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 1.1pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Chairman and Chief Executive Officer</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 20, 2020</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="HEIGHT:15.45pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Zackary Irani</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><i><font style=COLOR:black>(Principal Executive Officer)</font></i></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="HEIGHT:12.4pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Janet Moore</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 1.1pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Director, Chief Financial Officer, Treasurer &amp; Secretary</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 20, 2020</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="HEIGHT:15.45pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Janet Moore</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><i><font style=COLOR:black>(Principal Financial and Accounting Officer)</font></i></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="HEIGHT:12.4pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><i></i>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Allen Barbieri</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 1.1pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 20, 2020</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="HEIGHT:15.45pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Allen Barbieri</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="HEIGHT:12.4pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Francis Cano, Ph.D</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 1.1pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 20, 2020</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="HEIGHT:15.45pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Francis Cano, Ph.D</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="HEIGHT:12.4pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:15.45pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>/s/ Jane Emerson, M.D., Ph.D.</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 1.1pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 1.1pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 20, 2020</font></p></td></tr> <tr style=HEIGHT:15.45pt> <td width=156 style="HEIGHT:15.45pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Jane Emerson, M.D., Ph.D.</font></p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:15.45pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:15.45pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:15.45pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="HEIGHT:12.4pt; WIDTH:117pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:17.55pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:17.55pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;/s/ Mark Sirgo, Pharm.D </font></p></td> <td width=18 style="HEIGHT:17.55pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:17.55pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;Director</font></p></td> <td width=18 style="HEIGHT:17.55pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:17.55pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 20, 2020</font></p></td></tr> <tr style=HEIGHT:12.4pt> <td width=156 style="BORDER-TOP:0px; HEIGHT:12.4pt; BORDER-RIGHT:0px; WIDTH:117pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-AUTOSPACE:'><font style=COLOR:black>Mark Sirgo, Pharm.D</font></p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=276 style="HEIGHT:12.4pt; WIDTH:207pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=18 style="HEIGHT:12.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=168 style="HEIGHT:12.4pt; WIDTH:1.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 86A8386C -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit5_1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<head><title>Exhibit 5.1</title> </head> <body lang=EN-US> <div style=page:WordSection1> <div align=center>&nbsp;</div> <div align=center> <table width=824 bordercolor=transparent style="WIDTH:618.05pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.5in" cellpadding=0 cellspacing=0> <tr style="HEIGHT:142.95pt; PAGE-BREAK-INSIDE:avoid"> <td width=279 style="HEIGHT:142.95pt; WIDTH:209.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:10pt' align=center><font style="FONT-SIZE:6pt; TEXT-TRANSFORM:uppercase"><img width=163 height=51 style="HEIGHT:41px; WIDTH:146px" src=untitled.jpg></font></p></td> <td width=435 style="HEIGHT:142.95pt; WIDTH:326.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:6pt; FONT-FAMILY:"Swis721 Hv BT","sans-serif"; TEXT-TRANSFORM:uppercase'>Stradling Yocca Carlson &amp; Rauth, P.C.</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:6pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"; TEXT-TRANSFORM:uppercase'>660 Newport Center Drive, Suite 1600</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:6pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"; TEXT-TRANSFORM:uppercase'>Newport Beach, CA 92660-6422</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:6pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"; TEXT-TRANSFORM:uppercase'>sycr.com</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%'>&nbsp;</p></td> <td width=110 style="HEIGHT:142.95pt; WIDTH:82.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><i><u><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>CALIFORNIA</font></u></i></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; NEWPORT BEACH</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; SACRAMENTO</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; SAN DIEGO</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; SAN FRANCISCO</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; SANTA BARBARA</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 4pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; SANTA MONICA</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><i><u><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>COLORADO</font></u></i></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 4pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; DENVER</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><i><u><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>NEVADA</font></u></i></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; RENO</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><i><u><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>WASHINGTON</font></u></i></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 2pt; LINE-HEIGHT:8pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Swis721 Md BT","sans-serif"'>&nbsp;&nbsp;&nbsp; SEATTLE</font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 12pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>July 20, 2020</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Biomerica, Inc.</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>17571 Von Karman Avenue</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>Irvine, CA 92614</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in'><font style=FONT-SIZE:10pt>RE:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities Registered under Registration Statement on Form S-3</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>Ladies and Gentlemen: </font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>You have requested our opinion with respect to certain matters in connection with the registration statement on Form S-3 (the &#147;Registration Statement&#148;) to be filed by Biomerica, Inc., a Delaware corporation (the &#147;Company&#148;), with the Securities and Exchange Commission (the &#147;Commission&#148;) on July 20, 2020 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), relating to (i) the proposed issuance and sale from time to time by the Company of up to an aggregate of $90,000,000 of shares (the &#147;Company Shares&#148;) of the Company&#146;s common stock, par value $0.08 per share (&#147;Common Stock), and (ii) the proposed offer and sale from time to time by the selling stockholder identified in the Registration Statement (the &#147;Selling Stockholder&#148;) of up to 571,429 shares of Common Stock currently held by the Selling Stockholder or issuable upon conversion of certain shares of the Company&#146;s Series A Convertible Preferred Stock, par value $0.08 per share, held by the Selling Stockholder (the &#147;Resale Shares&#148;).&nbsp; </font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>You have provided us with a draft of the Registration Statement in the form in which it will be filed, which includes the prospectus (the &#147;Prospectus&#148;).&nbsp; The Prospectus provides that it will be supplemented in the future by one or more supplements to the Prospectus (each, a &#147;Prospectus Supplement&#148;) in connection with the sale of the Company Shares and/or the Resale Shares.&nbsp; The Company Shares will be sold, either individually or collectively, pursuant to one or more definitive purchase, underwriting, agency or similar agreements (any such agreement, a &#147;Purchase Agreement&#148;).</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In our capacity as your counsel in connection with such registration, we are familiar with the proceedings taken and proposed to be taken by the Company in connection with the preparation and filing of the Registration Statement, the Prospectus and the Prospectus Supplement(s), as well as the authorization, issuance and sale of the Company Shares and/or the Resale Shares.&nbsp; For the purposes of this opinion, with your consent, we have assumed that <font style=COLOR:black>(i) at the time any Company Shares are sold pursuant to the Registration Statement (any such time, the &#147;Relevant Time&#148;), the Registration Statement and any supplements and amendments thereto (including any post-effective amendments) will be effective and will comply with all applicable laws; (ii) at the Relevant Time, a Prospectus Supplement will have been prepared and filed describing the Company Shares and/or Resale Shares offered thereby and will comply with all applicable laws, (iii) at the time of execution, </font>each of the parties to any Purchase Agreement other than the Company (a) will be duly organized, validly existing and in good standing under the laws of its jurisdiction of organization; (b) will have the requisite power and authority to execute and deliver and to perform its obligations under each Purchase Agreement to which it is a party; and (c) will have duly authorized, executed and delivered each such Purchase Agreement; and (iv) with respect to each of the parties to the Purchase Agreement other than the Company, each Purchase Agreement to which it is a party will constitute its legally valid and binding agreement, enforceable against it in accordance with its terms. <font style=COLOR:black>&nbsp;</font></font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>In addition, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this opinion, <font style=COLOR:black>assumed the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies thereof and the genuineness of all signatures, and as to questions of fact material to our opinions, we have relied upon the certificates of certain officers of the Company.</font></font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%' align=center> <hr> <div style=PAGE-BREAK-BEFORE:always>&nbsp;</div> </div> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>Subject to the foregoing and the other matters set forth herein, it is our opinion that:</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>When (i) any and all Prospectus Supplement(s) required by applicable laws have been delivered and filed as required by such laws; (ii) the applicable Purchase Agreement covering the offer and sale of the Company Shares has been duly authorized, executed and delivered by the Company; (iii) the issuance and sale of the Company Shares have been duly authorized in accordance with applicable law, including, without limitation, by the adoption of resolutions of the Board of Directors of the Company (or an authorized committee thereof); and (iv) payment of legal consideration for the Company Shares, in the manner contemplated by the Registration Statement, the Prospectus, the related Prospectus Supplement(s), and any applicable Purchase Agreement, has been received by the Company, and assuming that (a) the Company Shares, as issued and sold, are as described in the Registration Statement, the Prospectus, and the related Prospectus Supplement(s); (b) at the time of the issuance of such Company Shares, the Company has a sufficient number of authorized but unissued shares of Common Stock under the Company&#146;s First Amended and Restated Certificate of Incorporation (&#147;Certificate of Incorporation&#148;); (c) such Company Shares, as issued and sold, comply with all requirements and restrictions, if any, applicable to the Company, whether imposed by any court or governmental or regulatory body having jurisdiction over the Company or otherwise; and (d) such Company Shares are issued and sold as contemplated in the Registration Statement, the Prospectus, the related Prospectus Supplement(s), any applicable Purchase Agreement, and such resolutions of the Board of Directors of the Company (or of an authorized committee thereof), such shares of Common Stock will be validly issued, fully paid and nonassessable; and</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; LINE-HEIGHT:normal; TEXT-INDENT:0.5in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>When the Resale Shares are issued in accordance with the Certificate of Incorporation and Certificate of Designation for the Series A Convertible Preferred Stock, as amended, the Resale Shares will be validly issued, fully paid and non-assessable.</font></p> <p style='FONT-SIZE:11.5pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:10pt>This opinion is for your benefit in connection with the Registration Statement, and may be relied upon by you and by persons entitled by law to rely upon it pursuant to the applicable provisions of federal securities laws. We consent to the use of this opinion as an exhibit to the Registration Statement and to the use of our name under the caption &#147;Legal Matters&#148; in the Prospectus which is part of the Registration Statement. In addition, we give such consent on the condition and understanding that (i) this letter speaks only as of the date hereof; and (ii) we have no responsibility or obligation to update this letter to take into account changes in law, facts or any other developments of which we may later become aware.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 3in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Very truly yours,</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 3in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>STRADLING YOCCA CARLSON &amp; RAUTH, P.C.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 10pt 3in; LINE-HEIGHT:115%'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:115%'>/s/ Stradling Yocca Carlson &amp; Rauth, P.C.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: D5FA5DC0 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit23_1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<head><title>Exhibit 23.1</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Bold">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman">Biomerica, Inc. and Subsidiaries</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman">Irvine, California</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman">We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ) of Biomerica, Inc. and Subsidiaries, of our report dated August 29, 2019, relating to the consolidated financial statements as of May 31, 2019 and 2018 and for the years ended May 31, 2019 and 2018. We further consent to the reference to our firm in the section on Experts.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman">/s/PKF, LLP</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman">PKF, LLP</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman"><br>San Diego, California&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; FONT-FAMILY:Times-Roman">July 20, 2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3.5in; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: F0CBDFD2 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )8#=X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?R'H?\0MR[_H.7WK_,_46^_:1\!Z?)Y<VLQHU5_^&GOA]_T&X_RK\M+GX?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[_H"1_G7K5%'LX=@_MW-/^@F?_@3/)?^&8?A]_T!(_SH_P"&8?A]_P! 2/\
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MR7X)U.W>)K2--W^PM'U.7<]./B[E<FN:E)?<?DKM?^Y1]W[U?J.O[#/@5?\
MEG6=JG[ /@74'W))) W_ $SJ'A:EM#U(>*V0MVESI>A^8^ZG;O>OTE_X=W>"
M?^?J>L*\_P""=NA+=/Y-_)Y59_5L1V7WG;3\4.'9NWM)+_MUGY[[O>C=[U]X
M:[_P3RM8;?=87CO+7._\.^]3\O\ UGS4>PK=CTJ7B%P]5CS*O;U5CXQHKZBO
MOV"_&:W3I;P;XJQM6_89^)%K_P >FF^>*ETJB5^4]>GQAD-2UL7#7NSYVHKW
M&X_8O^*UK;O+)H7R+_TTK%;]EWXAJ^W^Q)/SJ.6I_(ST(<0Y14UABH/_ +>1
MY117?ZI\"?&>DW7V>XTB1)?^!5EZA\+O$NEINGTRX"_[C4K2_E.^GF6"J6Y*
MT7?S1RE%:4WAO4H(_,DL;@)_US:J/D2_\^\G_?#5$I*.YW1J0EJFB.BG^6__
M #RD_P"^*;AO^>;T<\>Y?,A***-WO570PHHHI@%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4W;3J*+ 'W?NTOS_P!^DHJ>5 /\R3_GH_\
MWW1YTB_\O$G_ 'W3**7)'L3RHL6^H7EM)OBN9XW_ .NC5=_X2C5?^?Z?_OMJ
MRJ*:CRZ(SE1IRU<5]R.RA^+WBJ"!(4U.?8O^VU;>G_M'>/-+A\N'5Y(T^E>9
M455Y?S'!/*<!45IT(OY(]ATW]K+XEZ7)YD&LR!JVK7]MKXJ1W4<DVL^9%_''
MY=>"44^:I_.S@GPUDU1WGA(/_MU?Y'T\O[>?C?SX]T_R?QUUEK_P4"U58(_,
MC^>OC6C;[5I[:KT9Y%7@?(*MO]FBO0^\])_X*'V<5OLO+-WEKI]/_P""BGA.
M2/%U8R1O7YR[?:C;[57UBOW_  /%J^&?#M6_[IKT;/TTTW_@H!X&OGV/');_
M /72NCTG]L[P/JT_EK/LK\J/N_=J1;B:'[LDB5:Q=1;H\FMX49'+^&Y1^9^P
M&D?M'>#M6NO)2_C0_P"^M=/IOQ2\,:E=?9X=6M3+Z>8M?B['J=]%]VZG3_MH
MU3+KVJQ?,NI72-_UW:K6-E_*>#6\'L)/^%B6OE<_;;_A)M*W;?[2M-W_ %V7
M_&I5UJP;I>PG_@:U^)MOXNUNUF2:/5KK>O\ TW:NGT_XX^+K&?SEU.XD/^^U
M7'&KK$\>MX.5H_PL6G_V[;]6?LDM];-TFC/_  *I1(&Z-7Y)Z;^UAXTTV[CF
M6ZD<K_MUU-G^W9XZM9DER'V]JOZ[3/ K>$V<P_A3C+YV/U(HK\V[7_@HAXN6
M;]]81[*ZK0_^"AMW)?H+ZSC2"M(XJE+9GBUO#/B*BK^S3])(^^J*^/='_;\T
M"2;_ $P>6E=CH_[<WPZO9W6[U(6L0Z/6WMJ?<^>K<&9_0OS863]%<^D:*\6T
MS]K?X::LFZ#78RM=%IOQZ\%:M'NM]7CD7_@/^-7SQ[GBU<DS.C_$PTUZQ9Z/
M17/Z?XTT75(4F@OX9$?[OSBM9;R!NDJ'_@56>3.C4INTXM/T+5%1>?'_ 'E_
M.GJRMTH,AU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ_,^SNB?W*XC4O\ @G;J[>?]EOXT_N5/U>J?04/$;AZMO7Y?5'Q;17U5=_\
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MHM;5GXNTC4/]1?PO_P #K\4+'Q!J6FR;H+N>/Z2-74Z;\;/%VD_\>^IW$?\
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M!VW%C<1[?]BLM]T)VNFQJGF2U9Z<*D*BO%W0E%)NI-U',NYH.HHHJ@"BBB@
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M4?5-&E1113.4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^R"O(=<_X)X^*H9))+&^CD3^",UA+#U8K:Y]Y@_$3A[%J[K\G^+0^1**]O\
M%'[(_C;POYGF6LD^W_GFE>6ZQX'U[1+KR+K2KH/_ -<&K%\T5[RL?:X3-\!C
ME?#5HR^:,*BIY;&[M_\ 6VDD?^^E5MU*YZRDI:ICJ***8PHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA_\ M4>#O'OD+#=I:O)VDD6O6K75K'4$W6]W#-_US=6K\/(+ZYM3^ZN)(/\
MKF^VO1/A_P#M!>+?A_.C6E]/,B_P22-79'&V^-'XWFWA#!WGEE>W:,E?\?\
M@'[(45\%?#K_ (*#3S2)'XD@CA"_\M*^G_!'[2'@?QV((].U:-IY/X)/EKMA
M6A4^%GXQFW!^=9.W]9H-I=5JOO/5J*@CN(YON.C_ .Z]3UN?%A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)Q%*-5224E<^?JYS1HU'!Q>A^RWVB/\ OI_WW1]HC_OI_P!]U^-/_#7GC_\
MZ#4__CW^-'_#7GC_ /Z#4_\ X]_C6_\ JIB?YU^)E_;U#^5G[+?:(_[Z?]]T
M?:(_[Z?]]U^-/_#7GC__ *#4_P#X]_C1_P ->>/_ /H-3_\ CW^-'^JF)_G7
MXA_;U#^5G[+?:(_[Z?\ ?='VB/\ OI_WW7XT_P##7GC_ /Z#4_\ X]_C1_PU
MYX__ .@U/_X]_C1_JIB?YU^(?V]0_E9^RWVB/^^G_?='VB/^^G_?=?C3_P -
M>>/_ /H-3_\ CW^-'_#7GC__ *#4_P#X]_C1_JIB?YU^(?V]0_E9^RWVB/\
MOI_WW1]HC_OI_P!]U^-/_#7GC_\ Z#4__CW^-.7]KSQZO_,:G_\ 'O\ &C_5
M3$_SK\0_MZA_*S]D_M4"_P#+:/\ [[%'VR#_ )[1_P#?=?B/JO[1WQ,U*^DN
M(O%%Q O]P;JI_P##0/Q/_P"ALN__ !ZMEPE7ZU%^)']O4OY6?N)]L@_Y[1_]
M]T?;(/\ GM'_ -]U^'?_  T#\3_^ALN__'J/^&@?B?\ ]#9=_P#CU'^J-?\
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M_P#Q[_&C_53$_P Z_$/[>H?RL_9;[1'_ 'T_[[H^T1_WT_[[K\:?^&O/'_\
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M%%% !1110 445@:QXTT/P^'.H:E;VH3[V]^E4HN3M%7$VHZLWZ*\2\8?M9>
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M9$C^;^]]:C_X:\\?_P#0:G_\>_QK[3_5/%?SK\3YS^W:"=N5G[+?:(_[Z?\
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MY_&C_5?&^0?VWAC]9&N(U_C7\Z;]HC_OI_WW7X\Z]^V=XXUF^^T6^I3P1?\
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M_CW^->E_JIB?YU^)Q?V]0_E9^RWVB/\ OI_WW1]HC_OI_P!]U^-/_#7GC_\
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M]E!!')823;?O_P"<US2X9QZV29O'.L*]S].:*_/K1?\ @J?9W4WDW7AKR_\
M;W__ %Z]-\'_ /!0;POXA_X^[>.R_P"!_P#UZX*F1YA25Y4SJAF>%F[*9]<4
M5XYX:_:E\ >(1L&NP02>DCK7?Z7X^T#6_P#CRU:WG_W9%KR:F&K4OC@U\CNC
M6IS^&29TE%-5E;D4ZN<V"BBB@ HHHH **** "BBFLVU<T ,::./[SJOXTW[1
M'_?3_ONOS9_:\_:>\1^$OB-?Z/H^K20>4_\ JXZ\/_X:\\?_ /0:G_\ 'O\
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MNK2)_G^]7+BN'*^$HRK3FK(WHYQ2KU%3C%ZGZ$T4U?NTZODCW@HHHH ****
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M]:/[/@]:Z%PQ@%W,_P"VL5Y?<?I,W_!1C3/,_P!7'L_S[T?\/&M-_P"><?\
MG\:_-O['%1]CBK?_ %=P'8Q_M?%=S])/^'C6F_\ /./_ #^-'_#QK3/[D=?F
MW]CBH^QQ4?ZNY?V#^U\7W/U$\+_\%$/"=Q _]J2) _\ !_G-:_\ P\(\ ?\
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MJ*&^Y0!ZE^R;H;:Y\?M!A\O?%O\ G_2OVHL[=;6UAB3Y51545^6?_!/?P?\
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MA)_WPU'V/4/^?%_^^&HNNX#:*;MG_B@^>AF:+_6?)3 =14:W$3?\M*<LBM0
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M_P *ZJ>882I\%1,PEA*\-X,\EHK4UCP7XGT.Z^SS:%=_+_RT\AJRY+6^M_\
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MU^W93E\<OPZI_:>K9^:X_%O%UG+[*V"BBBO:/."BBB@ HHHH **** "BBB@
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M&\CC9=)NDW?[#5E*K3C\4E]Z+5.;V1QM%>M:?^RCXZU*#SEM)T_X W^%6/\
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M/4_1LKK.MAHWZ#Z***^=/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O<6\5S'LE1'0
M]FKSOQG\ ?!WC2&;[5I,"7#C_7;.:],HJ914E9G9AL9B,'-5,/4<&NSL? 7Q
M,_X)ZSVL=WJ&@ZEYV/G2WV5\I>*_A'XI\%22?VCI,\$2_P#+38U?M57.>*/
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MBTDLKB)]GER5^CX',</F$.:C+7JNJ/D,5A*N%ERU$5:***],X@HHHH ****
M"BBB@ IK+NIU% 'TC^Q'\?=2^&?CN#P[-/\ \22Z?YWD?Z5^L^GWT.I6D=S;
MOOAE7<KU^ OVJ?39([BUD\B577]Y'7[&?L@_$:/QM\)])ADE\V]M851Z_-^*
M, DXXN"WT?\ F?7Y'BG*]"3]#WFBBBOSP^N"BBF22>6C,>@H ^.O^"A/Q';1
M?!?_  CZR;/MJ?XU^7EC'Y<&W_;:OK+_ (*.^-$\2_$S3;6SD_=6NY'KY57M
M7[5D.'^KX"'=ZGYQFE5U<5+L@HHHKZ$\D**** "BBB@ HHHH **** "BBB@
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M_GW^0?V#+^<_$;_A#=:_Y])_^_#4?\(;K7_/I/\ ]^&K]N?^%0>$/^@#:_\
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MS=;,\97_ (E1GLT\%AZ?PP1@VO@W0K.-(X=)L45?2!:N+X?TU>EA:C_MBO\
MA6E17FN4GJV=?*NQ273+->!:0_\ ?M:=_9EK_P ^T/\ W[%6Z*5V.R*G]F6O
M_/M#_P!^Q36TRS;@VD/_ 'PM7:*+L+(S?[!T[_GPM?\ ORM0R>%=&E_UFE63
M[O\ I@O^%;%%/F?<7*NQP&O_  3\(^(82DVDVZ;O^>:+7D'BO]@GP!XKW^9&
M8-W]ROIZBNRCCL50=Z=1KYG/4PM&I\<4S\WOB=_P38GTFWG;PG))=.OW*^2?
MB%\'?%_PINGA\26$\']S8C/7[KUR?C3X9^'?'UK)#K.F07>Y-FYTYKZ?!<3X
MBBU'$>]'\3QL3DM*I=TM'^!^$D<RRQ[EJ2OK[]JK]B"Y^'\UWXB\,I)=:>WS
MO!&GW*^/XV;[LD>QU^3RZ_2<)C*..I*K1=T?'8C#U,-/DJ+4=1117:<P4444
M %%%% !1110 58TG6KSPSK$&I:?))!<*ZOYD?^S5>AON4FD]&KH$[:H_9']D
MWXT6OQ<^'-HROON[.)4FKW*ORN_X)Y?%!O!WBK^P9)]GV]_]7^5?J>K;ES7X
MGG6#^I8R48KW7JC])RW$?6:"DWJMQU%%%>">H%%%% !1110 4444 %%%% !1
M110 4444 12S+!&TC_*BU^>'[?7[3<DTS^"=!NP+=O\ 73QO7T!^V-^T9:?"
M'P//:V<Z2:M=(R".-_G2OR6U34KS7M8GU+4)Y+JXE??YDG^U7WW#>4^TE]<K
M+1;+S/ELXQW(OJ]-ZO<JPQLOS2?.[??DJ2BBOTT^+"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#L/@SXNN?!?Q-T6XMY-B2W"[_^^J_;WPWJ46K:!87<
M+[TE@1O_ !VOP2M[C[!J4%XOW[=]]?KQ^Q#\0)/'WP@M+B5][1?)7Y_Q7A>:
MG#$);:,^IR*M:<J7<^BZ***_-#[0**** "BBB@ HHHH **** "BBB@ HHHH
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M6,J>RP\Y>1^7DVH-K-U/>-]^69J*KV*[8-O^VU6*_>;6T1^7L**** "BBB@
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MB99_%3P18:Q;.N]T7>E>A5[R?,KH_A7%8:K@Z\\/65I1;37H%%%%,Y0HHHH
M***CDD\J-W;HM 'P%_P4?^(#63V_A_S/DN$^Y^=?GO:Q^5!MKZ@_X*&>*(O$
MOQAM%MY/W5O\E?,M?M^2451P%-=6KGYIF51U,5-WV"BBBO</-"BBB@ HHHH
M*&[T4UO]70![-^R+X-;Q1\7M%O/+W_99M_\ X]7[,6Z[84'HJU^;O_!,;P:F
MIZEJ>J7"?\>OW/TK]*:_(^)Z_M,;[/\ E5C[W):?)AN;NPHHHKY ^@"BBB@
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MU'P;_P"2T^$_^OE?_0JPK_PI^C_(VH?Q(G[HV'_(/M_^N2_RJU56P_Y!]O\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@?_@J5IL<?A'2;P/\
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MQ;!KFJ6GF:)"ZO\ /]WY:\?^#/PIU?XQ>.+#3=-@D^SQ3+YTG^SNK]EOA/\
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M*L<XQCA8==6?5Y'AN9NO+IL:5%%%?FI]D%%%% !1110 4444 %%%% !1110
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MK4Z:Z(^UR&#5*4WU)J***^#/J#EOB)XB3POX2U*];^"%O_0:_#?QE=-?^/\
MQ#=-)O\ -N&?_P >K]8_VY/%3>%/@S=W"R;&?Y:_(B2;[9=3W7_/5]]?I_"=
M#DHSK/KI]Q\5GE6]2-/L.HHHK[P^7"BBB@ HHHH **** !N]?3G_  3U\%IX
MR^(TEPWW+)]_\J^7[B3;'7Z'_P#!-?P*VAV^IZHR?\?2+7A9Y6]A@*C6[/3R
MVG[3%0\C[UC3:BK_ ':?117XB?I04444 %%%% !1110 4444 %%%% !1110
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M]+R_#_5\/&+W>K"BBBO$/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L#QNVWPGJQ/\ S[2?^@FM^N0^*EXEA\/M>FD?8JVDG_H-:4TY
M5(I=T1/X6?B?\4KJ*\\?ZDT/W/.;_P!"KFZ;J5UYGB/5I&??_I$G_H5-\Y*_
MH2$>6$8]DC\GD[R;)**C\Y*/.2K))**C\Y*/.2@"2BH_.2CSDH DIK?ZNF^<
ME-DN%^[_ 'J!'V!_P3G\$IXB\32:DW_+J_\ A7ZCJNU<5\2_\$S?"+Z#X'U:
MZE3YK@KM>OMROQCB"M[;'S[(_1LIIJGA8M=0HHHKYL]@**** "BBB@ HHHH
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MJJF!]VGU^'XG$5,55=6H[MGZ71HPH05.&R"OG[]LKX>?\)Y\*;M=F_[*C/\
M^.U] UA>,M/75/"VIVC)O\VW=?\ QVGA:SH5X58[IA7IJK3E!]4?@O,OE:C=
MV_\ SR=DIU=1\6O!LO@/XA:E8R?\M9F?_P >KEZ_?:<U4@I1V9^5RBXR<7N@
MHHHK0D**** "BBB@ H;O110!]"?L/_$;_A#?B=INC^9L^V/7Z]PMNC1O]FOP
M:^'>M?\ "+_$+1=8\S9]GF7]Y_P*OVX^%7BH>,_ NDZL'W_:(5/_ ([7YCQ7
MA^2K"NEH_P S[3(ZRE3E2;U1V-%%%?!'U(4444 %%%% !1110 4444 %%%%
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M04444S4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[21-"1U\Z>1-E?K3\'?@_HWP@\*VNEZ9!&CH@\R4+]ZOD\ZSF&!@Z-)WJ/\
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M***\H[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5GWTWRP;[(_'G]H3Q,WC#XH7=\TF_P#?,G_CU<#1<7DNI:M?S3?._P!HD_\
M0J*_H"E3]E3C371'Y3.3G-R84445J0%%%% !36_U=.J&Z;;!_P #6F@/M?\
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M^<7_  \HU?\ Y\(_\_C1_P /*-7_ .?"/_/XT?ZNYA_*']KX7N?H[17YQ?\
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M6?UW&2FE*+NF%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?FEY*4>2E'^K6 _E8?VQB^Y^EO\ P\HT#_H&_P#C_P#]>C_AY1H'_0-_\?\
M_KU^:7DI1Y*4?ZM8#^5A_;&+[GZ$ZU_P5,L--NO*M_#7VE/[^_\ ^O69=?\
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M:_CQYD;\I7Y9^=/>3R7EU)Y]W*[.\DE==\7OB1J?Q:\>:EJVI3R3Q><WV?\
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MO^?]/^_BT?\ #6/@;_G_ $_[^+7F_4<3_(SM^LT?YT>V45XG_P -8^!O^?\
M3_OXM'_#6/@;_G_3_OXM'U'$_P C#ZS1_G1[917B?_#6/@;_ )_T_P"_BT?\
M-8^!O^?]/^_BT?4<3_(P^LT?YT>V45XG_P -8^!O^?\ 3_OXM'_#6/@;_G_3
M_OXM'U'$_P C#ZS1_G1[917B?_#6/@;_ )_T_P"_BUC^(/VTO F@_P"LN]_^
MY(M5' 8J3LJ;$\50CJYH^A**^3]9_P""B'P]T:#>WF2?[E<EJW_!3SP9Y+BQ
MLY'?_;KJCDN/GM29A+,,-'[:/MVJMY?P6$)EGF2!!U+U^:'BC_@HWKEU)/\
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M_P#A-:W2R;_*"I7OE?@.)HO#UI4I;IGZG1J*M3C475!1117,;A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,959=I^
MZU/HH _/[]MW]G7[#-)XJT.T_=O\]QY:5\2U^WOC#PS;>+O#E]I%US%=1LAK
M\BOC]\,Y?A=\1=2TA4D^RH^Z-Z\C%4N1\ZV9_7/ACQ5+,L,\KQ4KU*:]U]X_
M\ \WHHHKC/W<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]\^ _PK?QQH
M-Q<B+<JO][_/UKP55:21(U^\WRU^F7["O@>7P[\,7FOK95N;AP067'RXS_6M
M:,74G;R/SCCS.7DN4NM!^\Y)(^IZ***]X_A8**** /G#]MCQZ/"GPOO+(2;/
MMT3+^AK\A;5=OF?[3L]??W_!4#Q@J6^B:; _S_-O_6O@6-=L=?L'#5#V.!4[
M:RU/S[.*OM,3;L.HHHKZL\,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** -SPCI.GZU)Y-])L?^"O<O O[/_@?
MQ!Y<>H:DD%Q_OU\YQR-')YD<FQJN0^)-:M9/,AOY$>N'$4:M32G4Y3HI5(0?
MO1N?H!\/?V&/A+K-O'=2:LDEQ_SS\Q:^B?!7[,?@/PCY#6UO!<>5]SS-K5^0
MUK\2O&-A_P >NNSP?\#:NJ\._M+?$70;B-I?$L\T*_\ +/YJ^6Q639A7O_M-
MU_7D>[1S+"4TN:EJ?M/9Z%I=D/\ 1;&UBV_W(U%:E?EMX%_X*/:YX5V1ZE:/
MJ*?Y]Z^COA9_P4&\+>.)DBU2WCT<?WW?_P"O7QV)R''T$Y.',O(^@HYIA:ED
MG9GUW17*>%OB9X:\:?\ ('U:WO?^N;UU=?/RA*#M-69ZT9*2O%W04445!044
M44 %?(W_  4<\53^'_A %M9-DLS[*^N:_-C_ (*2>-/MFL?V#Y_^J_Y9_G7T
M&14?;8^GY:GE9I45/"ROUT/A^-O-_?-]]JDIL:[8Z=7[6?FX4444 %%%% !1
M110 4V1ML=.JO>-LC3_?6F@]#[__ ."8/A&2S76]2N4P&V^5^E?H97SC^Q3X
M&;PS\+;&^:/9]MA5_P"5?1U?AV<U_K&.J37I]Q^E9;2]EAH(^:/VZO&$6B_!
MG4]-5_W]TG'ZU^1=CN:#<WW][5]Z?\%)_'36.N6&B^9_K4KX/AC\J/;7Z1PW
MA_8X!2_FU/D,XJ>TQ+7;0DHHHKZ@\0**** "BBB@ HHHH KWW^IK]6?^"?/A
M)-/^$]KJSIB6XK\N-#T_^V/$>FZ?]_[1,O\ Z%7[0_LV>$V\&_"G2-/9-FV-
M6_\ '17Q7%5;DPD:5]6_P/H\CI\U=S>R1ZQ1117Y2?=!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1R2K%&[M]U:DKF?B#
MJ@T?P7JUZ3L\JW=O_':J,>:2BNI,I<J;9^4G[>GBC^WOCU.L,F^U2OGVNJ^+
MGBA?&GC^_P!2CDWKYS?^A5RM?OF#I>QPU.GV1^68BI[6M*:ZL****[3G"BBB
M@ HHHH ***;)_JWH ]Z_8A\&OX@^-FF7S1[[>)Z_8>) L:*.BU^>7_!,WP2-
M2TZ[UQT_U#XWU^B-?D'$M?VN.<?Y58^_R:BZ>&N^HUCMYK\O/^"DWC9K[XA:
M9IEK)OMXOOU^FNM7"V>DWT[-M5(6;/\ P&OQ._:$\9-XW^*&K2-)O2WF9$_[
MZKHX6P_M,5*KTBC+/*O+05/N>=JNV.G445^KGPH4444 %%%% !6IX+\/R^*/
M&.DVL/\ #<1[_P#OJLNOH+]@_P $IXT^-/EW$?\ H\'S^9_NUR8NM]7H3J]D
M;X>G[:K&'=GZM_#W2TTGP7HMJB;!';1\?\!KIJ@M;5;2UCA7[B+MJ>OP&4N:
M3EW/U2,5%)(*CF7=&Z_[-245)1^07[<7@E?#/Q0U+5%C_P"/I_\ &OGE>U?>
MW_!4+PE]CTW1=6MH][RNV^O@>/\ U:5^X9-6]O@:<_ZT/S/,:7L<3-?,=111
M7MGG!1110 4444 %=%\+;QM-^*GAJZ5]B17"_P#H5<[4FGWW]EZQ87W_ #[N
MM1.//"4>Z*A+EDI'[R>$M6CUOP_874?W7B7_ -!K;KQ/]DOQ9_PF7P@TR^\S
M?\NRO;*_ ,33=&M.F^C/U6C/VE.,UU04445S&P4444 %%%% %34+^'3+22ZN
M'V01+N=Z_+']NK]H^?XC>*9/"^DW'F:%$VSS(Z^H_P!N;]I"V^&?@N31=,N(
MY]3O5:%TC?YTK\L-TMQ/)<7$F^:5]_[S_:K]&X:RO_F-JKT_S/D,XQW_ ##T
MWZA''Y4>VG445^BGR(4444 %%%% !113?+ENKJ"SA^>XN'V(E(#HOAKX#U/X
MH>-+31=+CDDE\Y=_^[NK]FO@9\*=.^$_@:QTRS@6.5T5YB/[VVO!?V%?V<X/
M OAB#Q-JEGY.MW"?QI7V'7Y-Q%FGUNK]7IOW(_BS[S*,%["G[:?Q/\$%%%%?
M''T)'(VV-VK\COV[/%S:]\4+[3?,W^0_^-?K)K-_'I>F75U,VQ(D9L_1:_$C
M]HC5O[<^.7B6\63?$\WR5]QPI14\3.H^B/F<]J<M&,5U9PB_<HHHK]3/B HH
MHH **** "O5/V2=#_M[]H#089$WV^_YZ\K;[E?5W_!/;P:VL>.(-8\C?]G?_
M %GY5YN9551P=63[,[,'3=3$0CYGZF6=NMK:QPH-JHJJ*LTU?NTZOP8_40KX
MQ_X*3^-)?#'P_P!,MX7Q]J=D:OLTG;7YA_\ !2#QF/$&N6^E>?O^RO\ ZO\
M.OHL@H>VQ\+[+4\C-:BIX67F?&\:_P 7][YZ=35_U=.K]I/SD**** "BBB@
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M]MCYI?9T/T3*:7L\+%]PHHHKYH]D**** "BBB@ HHHH **** "BBB@ HHHH
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M&E3JU5[9VBC[=\&>$[+P7X;L=(L8TCM[6)8QL]JWZ^7/^&[_  A_?C_[[_\
MKT?\-W^$/[\?_??_ ->OR665X^3<I4VVS[U8["Q5E,^HZ*^7/^&[_"']^/\
M[[_^O1_PW?X0_OQ_]]__ %ZG^R<;_P ^V/Z_AOYSZCHKY<_X;O\ "']^/_OO
M_P"O1_PW?X0_OQ_]]_\ UZ/[)QO_ #[8?7\-_.?4=%?+G_#=_A#^_'_WW_\
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MBBODCW@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KY$_;N^%$?B#P>FM6%GOOX3^]>.OKNN=\=:/%KOA+4K.9
M-^^!Q_X[652"J0<6?0\/YI4R;,J.,IOX6K^:/Q'9&CD>-OO+25TGQ!\,W/A7
MQ;J5G<1[#YK[/^^JYNO 75,_T(H58UZ4:L'=-7"BBBF;A1110 4444 %%%%
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MM]<^(J>QHSJ=D:TH>TJ1CW9^M_P9T9M!^&F@V3#:T=LH_P#':[.ZE^SPR/\
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M8']B/PG_ ,(E\#])MVCV3/\ ,]?)\2XCV."Y4]9.Q[N34E4Q-WT/H2BBBOR
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M_5/^>LS?^A5^A\)4'S5*S]/U/D<^J*T:?S,^BBBOT@^0"BBB@ HHHH ****
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M1.J]DOQ-\]J6I1AW9QB]J***_43XD**** "BBB@ HHHH *C;YKNT7^],J?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44T0FC9#T:I
M:* \S\M/VYO#B^'?BN/+^Y,F^OF^OLK_ (*)6L3>+K";^+97QFM>!67+5DC^
M^."<0\3P_A9RWY;?<.HHHK,^X"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KW_\ 9/\
M@'J'Q6\60ZE)'Y>EV#J\OF)]^N!^"_PEO_BUXNMM-MT<6[.N^39VK]8?A7\-
M=-^&/A6UTNP@1'5%\V3^^:Z</1]K)2>R/QOQ!XRAD>%>"PKO7J+_ ,!7?Y]#
MJ=(TFVT/3X+.SC$-O$NU46M"BBO:/XTE)R;E)W;"BBB@05X9^V/XJ_X13X%Z
M[=1R;+C9\E>YU\+?\%&O''V71H]#\S_6I_JZ]?*:#Q&-IQ\SS\?4]EAY,_./
M[<VJ3SWTG^NE=J=4-FNV#;4U?NEK;'YD%%%% !1110 4444 %:W@?3_[:\>:
M+I_E[_-F7]W_ ,"K)KU3]EOPO+XF^,OAZX5-Z6\WS_\ ?5<^(J>SHSF^B?Y&
MM&/M*D8]V?KI\&_#7_"*_#[2]/\ +\G9"OR?\!%=W5>U7;:Q+_=5?Y58K\ J
M3=2;F]V?JT8\L5%= HHHK,H**** "BBB@ HHHH **** (9K>.7_6(C_[U4+K
MPWIE^VZXL8)#_N5JT4TVM4Q-*6C.*U#X0^$=4W_:=!M9-W_3-:\T\?\ [&O@
M3Q=I[Q6FFP:=*W_+2.-?\*^@**ZJ>,Q%%J4*C7S,)X>E45I11^;7Q._X)IW6
MCV\^H:'J?VW;N?R-G_UJ^0/&7P[\3_#N^>WUS29[*)7^238U?O$R[J\^^*OP
M9\-?%G0YK'6+"&238WE3;/F1J^LP/$]>DU'%>]'OU/!Q62TIINCH_P #\/8Y
M%ECW+3J]P_::_9=UGX&ZJ^H*GF:([_)7AJMNCW5^F4,13Q--5:3NF?&U:4Z,
MW":LQU%%%=!D%%%% !1110 4444 1S*W^LCDV.K[_P#OFOU#_P""?_QTD^(7
MA&30;V;,VFHJ)O\ PK\P&[U]!?L/^,O^$5^)MI9^9L^U/_A7@9YA(XO!R36J
MU1ZF6XAT,1'L]S]@:*BA;S(4;^\M2U^)GZ2?/?[9OCP>$_A7?VP?8]["R5^/
M5JNWSV_O.SU^@O\ P5#\6>3INA:9;O\ -\WF_K7Y_1KMCK]?X:H*E@5.VLC\
M_P YJN>)<?Y1U%%%?6'A!1110 4444 %%%% #9&VQU]C?\$Y_ _]J>)H]>\O
M_5/_ *S\J^.9/F_=K]]J_3O_ ()K^$7T/X5W%Q<Q_OY7^_7SG$%?V. G;=Z'
ML95353%1OTU/LE:\1_:T\5?\(O\ "J_F\S9O5D_\=KV^OC;_ (*6ZXUA\(8[
M>&39+*]?EF5TO;8VE!]6?;XV?L\/.2['YDZA)]HUR_N/^>KL]1U';_-'N;[[
M5)7[ML?F 4444 %%%% !1110 4V9ML=.J&\;;''_ +ZT ?H#_P $O_"_V"WU
MZ^F3<TNW8?RK]"*^6?V#O"7]A_#6"]_Y^4_PKZFK\0SNM[;'U)?+[C]*RVG[
M/"P3"BBBO#/3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO FR&-=J)5FOPS&8JIC*TJU1ZL_3</0AAZ:IPZ!1117&= 445%(_EQNW]U:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO1:_ ,7+FQ%1^;_,_5<.N6E%>2"BBBN0W"BBB@ HHHH **** "BBB@ HHHH
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M  U5\.?^@['^5'_#57PY_P"@['^5?B]]LOO^?N3_ +[H^V7W_/W)_P!]TO\
M5/#_ //Q_@']NU?Y4?M#_P -5?#G_H.Q_E1_PU5\.?\ H.Q_E7XO?;+[_G[D
M_P"^Z/ME]_S]R?\ ?='^J>'_ .?C_ /[=J_RH_:'_AJKX<_]!V/\J/\ AJKX
M<_\ 0=C_ "K\7OME]_S]R?\ ?='VR^_Y^Y/^^Z/]4\/_ ,_'^ ?V[5_E1^T/
M_#57PY_Z#L?Y4^S_ &HOAY?W4=O#K<;3/]U,5^+?VR^_Y^Y/^^Z[7X%VM]X@
M^,.@Z?Y\CK+,O\;?WJBIPMAJ=.4W4>BOTZ&E/.ZTY**BM3]P=/U"#4K5+JW?
M?#(/E-6ZR/#.FIH^AV%FG2*)1_X[6O7YG*UW;8^RC>RN%%%%(H*8S*J9/W:?
M7SA^V!^T%9_"7P7/I]O/LU:]B9(O+?[E=.&P]3%552IJ[9C6K1H0=2>R/G?]
MO;]J'[3-/X)T&?9+$^R:2-Z^$57]Y)(WWV^_5C5-4N?$>JSZMJ$DD][<.SO)
M)4-?N. P5/ 4(T8;]?4_,\5B)8JJZD@HHHKT3D"BBB@ HHHH *;N7^_7H7P1
M^"^I_'#Q5!I=G'(EDS[)KK9]ROK>3_@E'9_P^+)-O_7.O)Q6:X3!S]G7G9G?
MA\#7Q,>>G'0^!MR_WZ-R_P!^OO?_ (=16O\ T-G_ )#_ /K4?\.HK7_H;/\
MR'_]:N+_ %ARW_G[^#.C^R<7_)^*/@C<O]^C<O\ ?K[W_P"'45K_ -#9_P"0
M_P#ZU'_#J*U_Z&S_ ,A__6H_UARW_G[^##^R<7_)^*/@C<O]^C<O]^OO?_AU
M%:_]#9_Y#_\ K4?\.HK7_H;/_(?_ -:C_6'+?^?OX,/[)Q?\GXH^"-R_WZ-R
M_P!^OO?_ (=16O\ T-G_ )#_ /K4?\.HK7_H;/\ R'_]:C_6'+?^?OX,/[)Q
M?\GXH^"-R_WZ-R_WZ^]_^'45K_T-G_D/_P"M1_PZBM?^AL_\A_\ UJ/]8<M_
MY^_@P_LG%_R?BCX(W+_?HW+_ 'Z^]_\ AU%:_P#0V?\ D/\ ^M1_PZBM?^AL
M_P#(?_UJ/]8<M_Y^_@P_LG%_R?BCX(W+_?HW+_?K[W_X=16O_0V?^0__ *U'
M_#J*U_Z&S_R'_P#6H_UARW_G[^##^R<7_)^*/@C<O]^G;O>OO=?^"4=K_%XL
M_P#(?_UJ^?OVD/V56_9\O8TAOI-0M'_Y;[*Z</G&!Q514J,[R?D8ULOQ%"#G
M4C9'A-%-CD\V/=3J]H\X**** "BBB@ HHHH *KWVY8-T?WU=:L4V1=T= 'ZX
M?L-^/K7Q%\(=,TII-]]:)\]?2M?F)_P38\>?9_'=_I-U/LB9/DWU^G*MNK\3
MSS#?5<=-+KK]Y^D996]MAHM]-!U%%%> >J%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 56N[@6MK++V1"U6:Y+XE>)K
M3POX-U.\NIO)7R'V_E1>VK-Z%*5>K"E%7;:1^9?[9'B]/%_Q4N)4Z0_)7@M;
M'B[5)=:\3:E=2/OWW#G_ ,>K'KYQOFE*?<_T1R?!1R[+Z&$CM"*04444'L!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4459TW3KO6+J.VLH'GN&^542DW8F4E!.4G9(K_>^5:]T_9Y_9@U[
MXNZO;W5S:20: C?OIW/6O8OV:_V)KC4?(\0>+$\A/O):2)7W7X>\-:=X5T]+
M/3;6.TMEZ)&M=M'"N?O5-NQ^ \8^)5' J>"RA\U39SZ1]//S.?\ AK\*=#^&
M.BPV.E6L:;%QYFSYJ[FBBO62459'\KXC$5L55E6KR<I2W;"BBBF<X4444 %%
M%% 'D7[3'CA/ _PQU.=GV&6)TS_P&OQ;U"3[1X@U*X_YZS,__CU?I=_P4N\4
M-I_PQM[&W?\ >RO\]?F7#\T>YOOM7ZSPM0]G@W5ZR9\)G=7FKJ'1(DHHHK[(
M^="BBB@ HHHH **** (VMY;R>"&'YW:6/_T*OVT_9OT&/0?A#X>C6/9(]NKO
M_P!\U^1/[/\ X?7Q;\5[#39(]ZM,O_H5?M=X3TI-$\.V%DOW8H57_P =K\[X
MLK>[3H+U/K<AIN\JC]#;HHHK\X/L HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "ORR_X*=?\E:T+_<K]29I!#&[GHM?DI_P4*\21>)?C% T+[TM
M_DKZ[A>+ECT^B3/!SJ26%L^K/FNBBBOUT^ "BBB@ HHHH **** "O2/V:]!G
MUSXT>&I8?N13?/\ ]]5YNWW*^IO^">/A/_A)/'$ETR;_ +*_^%>=F-7V.$J5
M'V9UX2FZF(A%=S]5;-=MK$/1%_E7CG[77BC_ (17X&Z]>*^R79\E>T1KM117
MQ#_P46\=267A^/0=_P EPG^KK\;RNB\1C*<?,_0\=4]EAYR\C\W9+YM6NI[Z
M3[\KM14-FNV#;4U?NMK;'YB%%%% !1110 4444 %%%0W3;8-U 'TM_P3Y\+_
M /"3?&B?S$_=6_S^97ZW0P^3"D:]%KX!_P"";O@];>2[UKR_FE3_ %E?H'7X
M]Q)6]KCVELE8_0<GI\F%3[A7X^_\% I&;]HZ^7^"OV"K\?/^"@/_ "<E?UT\
M*_[[+_"S'//]V7K^C/G^BBBOU@^$"BBB@ HHHH **** "M#PO_R,5I_UUC_]
M"K/IUKJ#Z3?074?WUEC_ /0JF2NFD..Z/W%^"W_),]!_Z]EKO*\X_9]OFU'X
M0>&[ANKVRUZ/7\_8E-5II]W^9^K47>G%KL@HHHKG-@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *R?$6IP:+HE]>7$B0QQ0LV]^G
MW:UJ^-_^"@WQN7P?X'_L'2KO_B:W'WHXWKNP6%EC,1&C'JSFQ-98>E*H^A\
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MYGS.>5.6C&FNIS:]J***_4CX@**** "BBB@ HHHH *V/ -BVJ?$;P]9K'O\
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MWU>IJV/'VG_V-\0M=T]?D^SS,G_CU8]?O<9<T5)=3\NE'E;3"BBBJ)"BBB@
MHHHH **** /0/V?_ !U_PK[XH:3-_!<3*G_CU?MEHMVE_H]C<QG<DL*MG_@-
M?@CI]U_9NN6%]_S[OOK]C/V2/B-_PL?X56-YYF_RD5/_ !VOSWBS"MQAB$MM
M&?69#62<J3]3W.BBBOS8^Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *^+?V^_BK;6?AR/P[97&V]W_O=E?67C;Q1!
MX/\ #-_J]Q_JK6)G-?D'\<?B++\4/B%J6M&1_*F?Y$KAQ=3EARK=G[/X8\/O
M,\S^O55^[HZ^LNB. ^]\S4445Y1_9(4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%:6A>'=1\37D=IIUM)=W
M$ORJ$2OL+X%_L'W.J>1J'C%)+2--K_9_[]5"$ZCM!'S&=<1Y=D-'VN-J)/HM
MV_D?./PI^!?B7XM:HEMIMI)'"W/GR(VROT1^!_[)?AGX8V-I=7=K'?:S&,O.
M_P#>]:]@\)^!](\$:5#8Z7:1P)$NW>JJ&KI*]6CAHT]7JS^3N*?$+,,^E*AA
MG[*CV3U?JQB1K&NU5VK3Z**[#\G"BBB@ HHHH **** "BBLGQ%JB:)HEY?-]
MV&)GII7:2$W;5GYC?\%$O'CZI\1I_#PDWK%_RSKY)5=L>VO2/VF/$W_"9?&3
M4]65]^YV_P#':\YK]XRVBL/A*=-=C\OQE3VM><O,****](XPHHHH **** "A
MOEHJ.;_4O0!]*?L"^#VU?XTVFK-'OMXGK]<5^5:^$O\ @F7X-BF\#W.N2I^]
M#[%K[OK\<XCQ'ML=)?RZ'Z%E%'V6&7GJ%%%%?+GMA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 8'C36+;0?"^I7ES*D,:6TGSO_ +IK\/\ XI>*
MI?&GQ"UJZF^=5N&V?]]5]_?\%!OC[:Z+X9?PKI%WC57^_P"6]?FVK-+))-)_
MK9?OU^I\+X&5"C+$3WEMZ'P^=8E5*BI1Z#J***^X/F@HHHH **** "BBB@".
M:3;'_O?)7Z0_\$UOAX_AGP[JFJS1Y^V!=C_E7YS:?I-SXBU*#3[/Y[AIE_\
M0J_:S]G/PA'X/^$^@VWE[+DVR^;7QO%&*]EA%27VCZ'):*J5^=_9/4&8(I9N
MBU^4_P#P4;\6?V]\5["WM9_]'M_D>OU)UZX6UT6_F/1;>1O_ !TU^('QH\9/
MXV^)6LW#?\L+ED_\>-?.\*T.?$RK?RK\SV,\J\M%4^YQJKMHHHK]4/A@HHHH
M **** "BBB@ JO?*TL'EK]]G6K%:G@O3?[<\>:+I_P#S\3+_ .A4G+E3D^@T
MKM)'ZL_L%^'4TCX'Z;<-'LN)?OU]+5P7P8\)CP;\/],T_9LVQ*W_ ([7>U^!
MXZK[?$U*BZL_4L+3]E1C!]$%?CY_P4";_C)*^K]@Z_)S_@HAH:V_QHN-26/Y
MW_C_ #KZ/A:2CCG?K%GDYVKX9>I\OT4+VHK]:/@@HHHH **** "BBB@ JO>+
MNCC_ -]:L4V1=T= 'Z]_L5^,AXA^$^FV7G>8;2+;7T57YF?\$X_BXN@ZY=Z'
MJT^Q+KY(?,_"OTQ4[N:_$L[PKPN-G'H]3])RVLJV&B^JT'4445X)Z@4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4455OKZ#3;5[FY=888
MUW/(W04;Z";MJSG_ (C>-+3P#X1U'6+J2.-;>)G3?W:OQ@^.WQ8O/C-\0KO7
M)G?RM[(D?_ J]\_;@_:D;XA:Q/X6\/SN+.U?9*\;_?KY'CC5:_6N'<J>#I_6
M*J]^6WDCX3-L=]8G[*F_=7YCJ***^Q/G@HHHH **** "BBB@ KU#]F'X:S_$
M[XKZ99M://IGG?/)_!\M>6K'+=74%K#'OEN'V?\ ?5?JK^P?\!Y/AGX _M#5
MK=/[1N]KH[_?1:\+.<<L!A7+[3T1Z>7X5XJLET6K/IGPWH-OX;T.TTVU39#;
MH$6M>BBOQ)MR;;/TE)15D?+_ .W=XX30OA1?Z5')LFND_P :_)2QW>1N;[^]
MJ^W/^"EOCH_\)IIFCV[[UV?/7Q3&NR/;7[)P[A_88"+_ )M3\]S>M[3$M=M!
MU%%%?3'BA1110 4444 -D_N_QM7Z0_\ !,GP?]B\!W^I7<&R5W^3?7YP6<;7
M&N:9"O\ RUF5/_'J_:C]FKP6G@SX7Z9$J;'GB5__ !VOCN*,1[+"*DMY,^@R
M6ESUW)]$>MT445^2GWH4444 %%%% !1110!^:7_!3/PDTOC32=4C3Y%3YZ^)
MXVW1U^IO[?\ X';5/AS/K*IE;5/\:_*RQ;=!N_VVK]FX>K>UP$5_+H?G>;4_
M9XJ3[ZEBBBBOI3Q@HHHH **** "K6@ZDVAZY:7R_PS+_ .A55IK+NI-733"]
MM4?H[\=?VGM/\(?LUZ%:Z/>1W6I:E;^3+L?YH_EK\XMTMQ/)<7$F^:5]_P"\
M_P!JK%QJ5S?P1V]Q)(\47W(Y'J&O+R_ 0P$)0CJV[L[<5BI8J2<NBL%%%%>J
M<04444 %%%% !1;VLNJ:E::;;Q[[BZ?8E1S2>5'NK[._81_9@_X2C6T\5>)+
M3S+>W^>W\S\*X<;C*>"H2K5'M^9TX?#RQ514X]3Z5_8G_9\@^%_@J#5-1L?+
MUNX3YY)/OU]25%'&L,:HORJM2U^&XK$U,96E6J;L_3*%&.'IJG'9!1117(=
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M  CJO\[_ #O7YJV:[8(UK]<X7H>SP;F]Y-GP.=5.?$<JZ(FHHHKZ\\ ****
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M@ HHH;[E 'HG[,>F_P!L_'[PW;M]QYJ_;33[=;2Q@A3[J(JBOR;_ &#?!_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4O\ G^D_[[:C_53#_P X?V[6_E1^RO\ PUCX&_Y_T_[^+1_PUCX&_P"?]/\
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MK:#H.J7S1[/M07^E?F]?-MCC_P"NJ_\ H5?LU^R/X6BT'X.Z+.L>R6XA5_\
MQVOD>)Z_LL%R?S,]_)J7/B.;L>XT445^1'WP5E^(-/35M%OK-UWB6%D_-:U*
M*:=G=":OH?A]^T)\-;[X5?%#4K6^CV?:IF=/^^J\]K]/?V\/V;XOB!X??Q78
MIOU6R3[B)7Y@>7/:SR6MU'LN(G9'CK]ORC'QQ^%C)?$M'ZGYKF&%>%K./1[#
MJ***]L\T**** "BBB@ HHHH *&7=110!J^$_&&L_#_5H]2T*[D@NE?\ OU]L
M?!+_ (*/#3;6WT_QL'GN&VIY]?"5-:-6^;^.O-Q>78;'1M7C=]^IV8?%UL*[
MTV?MY\._CMX3^(EFDFGZG CM_!)(JUW]M?VUU_J9XY?]Q]U?@=8ZYKFESI)9
MZM/!M_YYNU>P>!_VQ/'O@&".&WG>ZV_\]'KXC$\)SO?#SOY,^EHY[%V5:-C]
MFZ*_,SPC_P %+/$[2)'JVFQHG_/2O9/"_P#P42\.7#_\3;RX$_S[U\_6R#'T
M=X7]-3U:>:X6I]JWJ?9]%?.&F_MY?"FZ@W7.M"U?^X1FM[2?VQOA;K7_ !Z^
M(8W_  KS99=C([TI?<SK6,P\MIH]QHKQ_P#X:J^'/_0=C_*C_AJKX<_]!V/\
MJCZEB?\ GV_N9?UJC_.CV"BO'_\ AJKX<_\ 0=C_ "H_X:J^'/\ T'8_RH^I
M8G_GV_N8?6J/\Z/8**\-U;]LKX6:*^VZ\11QGZ5S6N?M[_"^SV?8=72]_O<=
M/UK2.6XR?PTI?<R)8S#QWFCZ7HKX?\8?\%%M'M;C_B3B.:+_ #[UXYXR_P""
MD_C&622WTG38Q$W_ "TKU*/#V/K?9MZG'/-L+#[5S]-;C5+*Q&9[N"#_ *Z2
M*M>8?$;]I?P;\/+>1KK4X9G7_GE(K5^5?CK]I[QQ\08Y([B_GM=W_/-V_P :
M\ODU#5;K_CZU*>Z_ZZ2-7T&&X3M9XBI\CR*V>Z6I1^\^Z/C!_P %(VU2WGM?
M!8DM95^7S*^,_'7Q&\1_%"^^U>(;N>>7?O\ OM7/K&J_-_'3J^SPF6X; JU&
M-GWZGSV(QE;$O]Y+0:JJOW:=117IG$%%%% !1110 4444 %%-9MOS-76_#'X
M4^(_B_XC@TO0;223YU\V39_#6<YQIQ<YNR148N;48J[96^'?PYUSXL>)H-#T
M6!Y'E==\\:?)7ZX_LU_LVZ+\"_#$"QP1OK$R+]IG_P!JH_V:/V:=&^!?A.WA
M2!)]5E57FN)$^=6KW2OR;.\ZECI.A0=J:_$^[RW+5AE[2IK)_@%%%%?(GT 5
M\9_\%)/%RV'PG_LNWD_TJ5_FK[,K\JO^"AWQ EU3XIOX?63?:I_]>OI.'\/]
M8Q\.T=3Q\UJ^RPLO/0^2[?YDW-]]JFIJKMCVTZOV<_.@HHHH **** "J]\VV
MWJQ5C1;'^UO$>FZ?_P _$RI_X]2ORZOH&^B/TU_X)V^!UL_AK!KTD>R:XK[&
MKR;]FOPC_P (7\*])T_R]FU%;_QVO6:_",RKO$8NI4OU/U#!T_94(1ZV"BBB
MO,.T**** "BBB@ HHHH CF7=&Z_[-?D1^W)X)_X1GXH7^J>7L^U/_C7Z]U^?
M7_!4+PGMT;1-2MD^=G;?7U7#=?V6/C#^;0\/.*7M,-?MJ? *]J*;'_JZ=7["
M?GP4444 %%%% !1110 4444 %%%% !1110!'<2>5'N7YW_YYU]O?L"_LUR:_
M?)XTUJ#_ (E__+&"1*^<?V</A#??&CXBZ;;VT#O8V\R_:?[GWJ_93P3X-T[P
M+X?M=*TV!(((4"?)7Q7$>:?5Z?U6D_>EOY(^CRC ^VG[>:]U;>IN6\$=K"D4
M:[$3Y5%3T45^4GW04444 %%%% !1110 445'(VV-VH _/_\ X*B>)XYM!TG3
M;>3YXG^>OS^C_P!6E?2'[=GBYM>^*%]IOF;_ "'_ ,:^<5^Y7[?DE'ZO@*<7
MZ_>?FF8U?:XF<D%%%%>X>:%%%% !1110!7O%:6.-5^_YR_\ H5?M-^R?H\>E
M_ _PWMCV2RP[WK\@?ACH:^*/'VF:6WW)9E_]"K]MOA=H:^&_ 6CV"_=B@6O@
M.+:R]E3I=;W_  /J<BA><I_(ZVHYFVQNW^S4E<U\0/$ \,>#]3U(_P#+"%C7
MYK&+G)16[/LI244VS\H_VWO'C^)OBOJ6D^9O2U?_ !KY]7M74?%[6O\ A)OB
MAK6J>9O\V9O_ $*N7K]]P=)4,/"FELC\LQ%3VE:4O,****[#G"BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.0T_<E4+5%%%?GY]8%%%% %:[LX]0M9()DWPR+M9&K\ROVS_ -CZ^\(ZI?\
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MNK5%5ML!"MG$OW:D6-4^[3J*!!1110,**** "BBB@ HHHH ***;YG\*_._\
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M]I:Y86+?<N'V5^R?[)?@]?!/P@TRQ5-GR[J_)#X1Z#+XC^*GAN&'[GVA=_\
MWU7[B^'-,AT?1+&UA38D42C_ ,=K\]XLKVA3H+KK]Q]7D-%7E5[&E(VV-VK\
MD/V[O'3^(_BA?Z/YF_[*_P!ROU5\::\GAKPKJ6I2?=MX6>OQ(^-FN?\ "4?%
M;6M45]_FS-_Z%7G\*T.>O.LUI%?B=>>U.6C&FNK.17M1117ZD?$A1110 444
M4 %%%% !4;?\?UI'_>F5/_'JDJ]X9T6?Q!XFTVUA^=UN(_\ T*I<E%78)7:2
M/V!_9#\))X7^$]@5CV?:$5__ !VO=*X_X5Z?_9?P_P!!M]FS;:Q\?\!KL*_
M,54=6O.;ZMGZM0A[.E&/9!1117*;A1110 4444 %%%% !1110 4444 %%%%
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MP^5X?#ZVN_,JV-C;V$'E6T*0Q+_!&FT5:HHKYWU/7VT04444 -9MJYK\L/\
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MCV_9)/\ OBG?8[[_ )])/^^*_;VUW/S74;13OL=]_P ^DG_?%'V.^_Y])/\
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MQF-NJD[+LCZ##Y?A\/9QCJ06UO%:QB.*-(E'\*5/117BGI!1110 5X%^UO\
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M=_\ @%?LGY*?W!436%L_WH(V_P" "NF/%6,7Q13,)9'AWLV?C/\ \,B^/?\
MGA)_WPW^%9>N?LS^.-!C\R2PGF_X W^%?M5_9EK_ ,^T/_?L4R32;*7[]I _
MUC6MEQ9B+ZP1E_8-+I)GX?\ _"D_&?\ T";K_OAJ3_A2/C/_ *!-W_WPU?M]
M_8&G?\^%I_WY7_"C^P-._P"?"T_[\K_A6G^MM7_GT1_8,/YS\0?^%(^,_P#H
M$W?_ 'PU'_"D?&?_ $";O_OAJ_;[^P-._P"?"T_[\K_A1_8&G?\ /A:?]^5_
MPH_UMJ_\^OZ^X/[!A_.?B#_PI'QG_P! F[_[X:C_ (4CXS_Z!-W_ -\-7[??
MV!IW_/A:?]^5_P */[ T[_GPM/\ ORO^%'^MM7_GU_7W!_8,/YS\0X_@?XSE
MDV_V3=?]\-746O[)?CJZ@CF6WG^;_8;_  K]D_[!T[_GPM?^_*U,NFVB\"TA
M'_;-:B7%E=_#32*60T^LS\<M/_8W\>ZE/Y*P21_\ KJK/_@GG\1KQT59_+W5
M^LJZ?;+]V",?\ J98U7[J5A/BK&/X$D;1R/#QW;/RVL?^"9GCSSH&FU:/ROX
MTKT3P[_P3<N;>^W:E>1SV]?H317'4XCQ]3[5CICE&%7V3Y!\(_\ !/7P=:QO
M_;$"7#^U>E>'?V-?A=X9D\RST&,2_P#/0FO=**\NKFF,K?%5=O4[(8'#T]H(
MY30?AOX>\-_\>.F01_\ ;-:Z1;>./[L:+_P"IZ*\V4I3=Y.[.R,5'1(****D
MH**** "BBB@ HHHH **** "FL-W%.HH \HUS]FGP!XCURXU:^T6.:]G^_)FJ
MW_#*OPY_Z 4?YU[!178L9B4DE4?WLYOJU%ZN"/'_ /AE7X<_] */\Z/^&5?A
MS_T H_SKV"BG]=Q/_/Q_>P^JT?Y$>/\ _#*OPY_Z 4?YT?\ #*OPY_Z 4?YU
M[!11]=Q/_/Q_>P^JT?Y$>/\ _#*OPY_Z 4?YT?\ #*OPY_Z 4?YU[!11]=Q/
M_/Q_>P^JT?Y$>3:9^S'\/M(ODO+?1(TN$_CS7J%G:Q6-JEO"NR)/E459HK"I
M6J5OXDF_4TA3A3T@K!1116)J%%%% !1110 4444 %%%% !1110!Q7C;X2^&O
MB'_R&[!+NN3_ .&4_ANO_,!C_.O8:*ZH8JO37+";2]3"5"E)WE%-GC__  RK
M\.?^@%'^='_#*OPY_P"@%'^=>P45?UW$_P#/Q_>R?JM'^1'C_P#PRK\.?^@%
M'^='_#*OPY_Z 4?YU[!11]=Q/_/Q_>P^JT?Y$>/_ /#*OPY_Z 4?YT?\,J_#
MG_H!1_G7L%%'UW$_\_'][#ZK1_D1X_\ \,J_#G_H!1_G1_PRK\.?^@%'^=>P
M44?7<3_S\?WL/JM'^1'C_P#PRK\.?^@%'^=7-#_9O\!>']1@OK/18TN(CN1\
MUZI14O&8EJSJ/[V-8>BM5!#57:N!3J**Y#H"BBB@ HHHH **** "BBB@ HHH
MH *X+Q]\%?"?Q*NK>ZU_3$O98/N9KO:*TIU)TI<T'9D2A&:M)71X_P#\,J_#
MG_H!1_G1_P ,J_#G_H!1_G7L%%=/UW$_\_'][,?JM'^1'C__  RK\.?^@%'^
M='_#*OPY_P"@%'^=>P44?7<3_P _'][#ZK1_D1X__P ,J_#G_H!1_G1_PRK\
M.?\ H!1_G7L%%'UW$_\ /Q_>P^JT?Y$>/_\ #*OPY_Z 4?YTS_AE/X;^9')_
M8,>Y#N7FO8Z*/KN)_P"?C^]A]5H_R(S](TFUT2QCL[./R;>(;52M"BBN+5N[
M.G;1&9KN@V?B*Q>ROH_.MW^\GK7F4G[*_P .99Y)FT*/>_WN:]@HK>GB*U%6
MIS:7DS*=*G4UFKGC_P#PRK\.?^@%'^='_#*OPY_Z 4?YU[!16WUW$_\ /Q_>
MS/ZK1_D1X_\ \,J_#G_H!1_G1_PRK\.?^@%'^=>P44?7<3_S\?WL/JM'^1'C
M_P#PRK\.?^@%'^='_#*OPY_Z 4?YU[!11]=Q/_/Q_>P^JT?Y$>/_ /#*OPY_
MZ 4?YT?\,J_#G_H!1_G7L%%'UW$_\_'][#ZK1_D1X_\ \,J_#G_H!1_G1_PR
MK\.?^@%'^=>P44?7<3_S\?WL/JM'^1'C_P#PRK\.?^@%'^='_#*OPY_Z 4?Y
MU[!11]=Q/_/Q_>P^JT?Y$>/_ /#*OPY_Z 4?YT?\,J_#G_H!1_G7L%%'UW$_
M\_'][#ZK1_D1X_\ \,J_#G_H!1_G1_PRK\.?^@%'^=>P44?7<3_S\?WL/JM'
M^1'C_P#PRK\.?^@%'^='_#*OPY_Z 4?YU[!11]=Q/_/Q_>P^JT?Y$>/_ /#*
MOPY_Z 4?YT?\,J_#G_H!1_G7L%%'UW$_\_'][#ZK1_D1X_\ \,J_#G_H!1_G
M1_PRK\.?^@%'^=>P44?7<3_S\?WL/JM'^1'C_P#PRK\.?^@%'^='_#*OPY_Z
M 4?YU[!11]=Q/_/Q_>P^JT?Y$>/_ /#*OPY_Z 4?YT?\,J_#G_H!1_G7L%%'
MUW$_\_'][#ZK1_D1X_\ \,J_#G_H!1_G1_PRK\.?^@%'^=>P44?7<3_S\?WL
M/JM'^1'C_P#PRK\.?^@%'^='_#*OPY_Z 4?YU[!11]=Q/_/Q_>P^JT?Y$>/_
M /#*OPY_Z 4?YT?\,J_#G_H!1_G7L%%'UW$_\_'][#ZK1_D1X_\ \,J_#G_H
M!1_G1_PRK\.?^@%'^=>P44?7<3_S\?WL/JM'^1'C_P#PRK\.?^@%'^=,;]E'
MX;O\IT&,_C7L=%'UW$_\_'][%]5H_P B.:\'^ =%\"VGV?2+-+6+VKI:**Y)
M2E-\TG=G1&*BK15D<%X\^"OA/XD745UK^F)>RQ?=)KG/^&5?AS_T H_SKV"B
MNB&*KTX\L9M+U,98>E)WE%-GC_\ PRK\.?\ H!1_G1_PRK\.?^@%'^=>P45?
MUW$_\_'][%]5H_R(\?\ ^&5?AS_T H_SH_X95^'/_0"C_.O8**/KN)_Y^/[V
M'U6C_(CQ_P#X95^'/_0"C_.C_AE7X<_] */\Z]@HH^NXG_GX_O8?5:/\B/'_
M /AE7X<_] */\Z/^&5?AS_T H_SKV"BCZ[B?^?C^]A]5H_R(\>;]E/X;M_S
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M_P! */\ .C_AE7X<_P#0"C_.O8**/KN)_P"?C^]A]5H_R(\?_P"&5?AS_P!
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MZ@]YJ=W)/<-_MM6+17!*4ZGQNY^]95P_EN2P4,%14?/K]X4444K6/H@HHHH
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MNT?=7X&-HWAC3= M!;65I'!".VT5KJJKTIU%=!\1.<JDG*;NV%%%%! 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;O>K7-)7BKH\_$9E@\(KXBK&/JT>6T;O>OIOPQ^PAX[O9$_M:T^RI7L7A/\
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ML45LM-$?'UL16Q$N>K-R?FQH7;TIU%%!@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 44UFVU5EU*UA_P!9/&O_  *@
M:3>B+E%8MWXKT>S0M-J=I'M_Z;+_ (UY]XJ_:4\'>%YO+DOXYW_V'6I<DM6S
MT,-EV,QDN2A2E)^29ZW17RSXB_;Z\%:*_E0I)<R>U>:>*/\ @H9%=02?V7;O
M"_\ !7/+$THNW,?7X7@/B#%VY<,TGU>A]XUDZAXCTW21_I=[#!_OO7YA:Y^W
M%\1K_>MIJ7D)]*\\U[]H#QOXDDW7NK2.W_ JQEC8+1'W&#\(\TJ-/$U8Q7EJ
M_P C]7-1^,W@W2=_VG7K1-O^VM>9^+/VRO!V@^9]ENH[W;_GUK\NM0UR_P!3
MF\RXNIY'_P"NC509G;[TCUSO&5'HHGW6#\(LNI/FQ-:4_+9'WIXC_P""D-K:
M^9#IV@^<W\+[_P#Z]>0>+/VXO%6O;Q:[[7=_GUKYFJ159OE7YJPE7JRT;T/O
M<%P'P_@6G3PZ;[MM_F>@:Q\>O&^M32--KMQM;_EGYC5R.H>)-5U8[KR]GN-W
M]]ZJQZ9?2?=M9W_[9M6EI_@GQ!J)VPZ3='_M@U87<GK>Y]93H8#!J].,(+TB
MC#VTFVO9/#?[+7C/Q'#')':/!N_YZ1M7HFB?\$__ !KJ4 DFN8[53VK2-&;>
MD#R<5Q5DF#NJ^*BGZGRONI=U?>/@_P#X)[_9U_XG-PDYKU;PU^PSX TUS)J-
MB+X_6NA86JSX[&>)^085M0DY_P"%'YC6FDW^H-MM[:23Z)716'PD\8:I\UMH
M5T__ &S:OU:TC]F_P%H>/LNC1IMKN=,\,:9HT/EVMG#&OL@K18)O>1\1C?&&
MG'_<\-?_ !,_*'PW^RGXZUPHTNDSVJ-7K7A?_@GKK6M1H][J?V+_ (!7Z+BW
M1>B(/^ U*!MKH6#IVM+4^*QGBMG>(O[!1I^BO^9\8>'_ /@G7I6ESP276K?:
MMOWODKV7PO\ LI^!]!C_ '^DPW3_ .W7M=%=$:-..R/B,;QAGF8*U?$R^6GY
M'%:?\(?"6C_\>FAVL7T2NGL=*M--CVVT"0KZ(M7J*U22V/EZV*KXAWJS<O5M
M_F%%%%,Y@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHI-U "T5FW6N6%BF9KJ&,>[BL:^^)GAG3O]?J]JG_ Z5T=%/#5ZO\ #@WZ
M)G5T5YIJ?[0G@72X]SZ];O\ [CJ:XG7_ -L3P7IDVV&[CN5]>/\ &I]I%=3U
MZ&09KB?X6'D_^W6?0-%?&.M?\%%-(TZ2=;?2?M6S[GS_ 'ZX76/^"CVH7T;K
M:Z#]EW=/WF:YY8JE'1L^KP_AUQ'B-5A[+S:7ZGZ!M,J_>=:B:\@7[TR+_P "
MK\M/$G[9_B[6$?[/.]K7GVH?M ^/]2W^9X@N-C?[=9/&P6L5<^NPWA'FE97K
M5HP^]_D?K;K'Q%\/Z"FZZU.!/^!K7%ZY^U%\//#\?F7FM1HOTK\I+[XC^)-2
M^6XU>>3_ (&U8=UJ5S?_ /'Q<23_ .^]8/'/HCZS!^#^&C;ZUB&_\.A^G.N?
MMV> (;=_L%W]H?\ AXZUY9XH_P""A#0PO_9=O'.]?""KN^5?O5HV?AW4KZ3;
M!:SR-_N5C]<J2T/KL/X9\.X'WJB<E_>:/I?5/^"@GC:^1XX;>.!6KS?7OVH?
M&FO>9YE])'N_N.U<99_"OQ9?_P#'OHMU)_VS:N@TW]G7Q_J/S+H5PB_[:-6/
MM*TW:[^ZQ[]+*>%\MUC"G%^J_4X_4/&NO:G)YDVK71W?]-VK.DU&\FYENIW_
M -^1J^BO"_[$'BK7($:Z1[5V_P ^E>C:/_P3;N[R#S+SQ#]E?_GGY=5]7K2U
M2_$BOQEPU@'RRKQ5NRO^29\2LS-][YZ%C;_GG)_WQ7Z,Z+_P3XT+31 ;G4!<
MLGW\I]_]*]+T']D7P3I3QM+81S[?\^E;K!U&?,XKQ6R.C_!YI^BM^9^45O87
M=U)Y<5I.[-_TS:NLTWX/^*=7DC6#3)W\S[OR-7ZU6WP1\%6)#0Z#:(R]]E;]
MGX)T.PV&'38$V_=^3I6L<$[>](^2Q7C%!JV&PS^;7Z'Y6:;^Q[\3]49/*T60
MKZYKT'PW^P1XON)$_M2/R$K]+$C6/[J[:EK98.FO,^/Q/BQG=96IPA#T3O\
MBSXAT7_@G=I,WD?;KMT_OUWVD?L$^!-+FCE/F3LO]^OJ"BMHX>E'51/D,1QS
MQ!B?BQ4EZ:'EVB?L\^#M%C15TR%]O_3-:[FW\+:1:PI''IMJBKT_<K6Q16ZB
MD?)XC,,7BGS5JKD_-LIQZ?;6W^KAC3_=2K07;TIU%4<#;>X4444""BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNMK?[=3]>7\OY'5_Q!VKUQ2^X_7;_A<GA/>5_M:'Y?\ ;6D7XQ>%6_YBT/\
MWVM?CO\ \)IKG_02G_[[I?\ A--;_P"@E<?]_&J?KWD>A_Q!^E_T$_@?K9>_
MM*> ["Z>VEUF,2+47_#3WP^_Z#<?Y5^1%QJUY<S;Y;F=W_WS47]H7'_/Q)_W
MW4_7WV.^/A!EUES5Y7/UGU+]L#X8:5)LFUU0WTJK_P -K?"G_H/?^.5^3DDG
MG?ZQW>F?)4O'3Z6.R/A#DUK2JU+^J_R/U0U7]N;X<VK!;34OM*_WQ5!?V\/
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MABPF$T6DV^]?]A:W%\+Z4O33+0?]L5K6HJ[(\>IBL14=YU&_FS.70[!>190
M_P"XM3K86R](8Q_P&K5%,P<Y/=LB6,+]U<5+1100%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
64444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>untitled.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 untitled.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  T *,# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[C_X+,?\
M!9S5?V*?%D'PW^'%K83^-I[1+S4M3O(_.BT=).8XTBZ/,R_/E\JJLGRL6^7Y
M/T#Q9_P4J\:>'[?Q?8GXB26-[$+J'-O8PET89!%HRAL$=!Y?-8__  <.?LV>
M*OA3^W)+\4A8W%QX8\9PV<MK?B+S(+:ZMX(X'MG/(#8A60 \,KG&=K8^X_V'
M?^#@;X4?M$:;INC^/YU^''C*15BF:\/_ !*+N7 !:.X_Y9 G)VS;0O3>W6OV
M>CAHX#),/B\KP<,0Y*]1RCS-/2ZMOH[K316U6MS\QJUWB\UK8?'XF5'E=H)/
ME37>^VUGYW^1ZY_P2F^,'Q?^*'[*%YKOQTAN;/Q59:O=6RQW6D?V9<K:PQQC
M=+$%4;C)YO(500!QW//_ +#?_!93P1^W[^T3J/@3P=X8\36,.G://J[:EJIA
MB\Q8YH(M@B1G//G Y+<;3QS6A_P5V\5_&W2_V58-0^ K>9>>?)=:Y=P&R<)I
M M)FD=3<?*03L(,>7XXZU^(O_!-;_A?H^.^I_P##._G_ /";?V+-]L\K[%G[
M#YT'F9^U_N\>9Y/3YO3C->1E'#F$S?!XO,JG)3;^!<UHT]_B26B[?/0]+,<[
MQ&78G#X&'--+XG:[GM\/=]S^FRBORJ_X*/\ [7?[27['7_!/[X):EJOBRZ\.
M_%#6+V^M_$\JVEA,\Q#,\*G;&T(VQE1^[Q[\UY%IW_!3;]KG]MOX3>&M"^"^
MB^*9G\,Z=%#XJ\266G0M/JE_RS?O=OEQ+MV81-KD[B>" /&PO F+Q%%8F-6F
MJ;E*+DY62Y6U>]MFUI;>Z/2Q'%N&HU70E3GSV3Y4M7=)VM?=7UOV9^V5%?G[
M^VU\._VP/B?KOPML_@YKVI^'(5\(6[^)[R[O(+6!=1/WQ)N#.TOJ$4@8[5\@
M_M9?%O\ ;X_X)O0Z5XB\9_$&34=!OKL6D5_;M:ZE8R3[6<0NLD0=2RHQ&4&=
MK8/%99=P>\:H*EBJ7/*]HN3YM&^R?:_H:8WB185R=3#U.2.\DE;\S]P**^8?
M^"=G_!0:#]JO]@X?%CQ>MCH,_AU+R+Q))"&%K"UHGF23(#DA3$4?;S@D@$X!
M/YG>.O\ @K3^U!_P46_:4E\*_ C^T_#VFL\CZ;I6E1P)<_9D('VB[NI.%/(S
M\ZQ@N%&3@MAEW!V.Q6(K4).--47:<I.T5\_E?M;<UQO$N$P]&E52<W5^&,5J
M_D?0O_!T7=RVWP-^%PCDDC#ZU>!@K$;AY,?6I_V4;F2S_P"#:77I8G>*1- U
M]E=&*LI_M"YZ&OA[_@J!\4_VE;/P%X4^''[1FD,;[2;V;4]&UN186>]B9%1X
MO-MR890IV'_GHN[YL[EQ]O?LL_\ *L[XA_[%_7__ $ON:_0,1E[P>18'#RE&
M=L1'6+O%IN;33/CZ&,6)S?%UE%QO1EI)6:LH[H\S_P"#6Z]FOOB?\7WFEDF?
M^S-.^9V+'_6SUUGP_P#V)/VMM/\ ^"PS^-]0U+5_^$.7Q,]]<:VVKJVGW6B^
M<6%H(=^[F$^4(MGR-@]%#UQW_!K)_P E*^+W_8,T[_T;/4/P^_X*A?';Q'_P
M6%3X:7?CZY?P0OQ(N=#_ ++73;-$-FE])$L1<0^9]Q0,[L\=<U>:4\;+.\Q^
MIJ%O9+FYT]N1?#;KZZ;7(R^>&CE>"^LN=_:.W+;?FZWZ>FI^SM%?C]_P6!_X
M*=_&3]D7_@H='X?\,^,;VR\&65IIM_-H\5I:D3JP#2IYCQ,XWX/\7&>*XWXV
M?M>_MY?M,^!M1^+?A/0O$O@?X66T,FH6<.DI!"8[-,MYQWXN;A=@R9 NPC+*
MJKT^+PW 6+JT:.)G6IPA42:<I6WVCMJWY7]3ZFOQ=AJ=6I0C3G*4'9I*^V[W
MV]3]LZ*_-'_@A-_P5B\8?M?>)-;^&GQ+NXM6\2:7IYU72]7$"0RWD".D<L,P
M0!2Z^8C*P )&_.2,GRG]I#_@KA\=/VSOVQI_@Y^S2\&BV,5[-8V^I)'"USJ8
MAW&:Z>64,L, ",R[0'*@9)9@@Y5P1F'UZI@IN,?9KFE-OW%'H[VOWZ='?8V?
M%6"^J0Q4;OG=E%+WF^UO^#U7<_7G7M?L?"VC7.HZG>VFG:?9H9;BZNIEAA@0
M=6=V("CW)K#^''QK\&_&(7A\(^+?#/BD:?L%T='U2"^^S;]VS?Y3-MW;&QG&
M=IQT-?A/_P %'O&'[5W[/.@:=\-?V@?%EUXC\#^,)H;\264T$JWPMI5:2..X
M\H2*Z%D)5QM!,;;3Q7ZL?\$K?V./A)^SE\(7\:?".Z\376C_ !5T[3M1D;6;
MM)I%2)9FC7"(H1U-Q(''/(QVJ\VX7H9?ERQE2OSRF_<Y%>#M:]Y.S3WTMT^Z
M<OS^KC,:\-"ER**][F=I*][66MUMK?J?4]%%%?&'TYD^.? >B?$[PI>:%XCT
MC3M=T;48S%=6-_;I<6\Z^C(P(/Y5^2/_  6*_P""(7@+X)_ SQ!\7/A?+<>'
M$T!HI]3T">8S6DL4DRQE[=W)>-@TBG8S,I .W:0 W6_\%%=*_;A^&?[:'B[Q
MC\(4\73>!-4^RC3K;2I8=5M@L5M%&^;*3>4=G5R2(QG=U-?.GQ<\.?\ !0'_
M (*&Z-!X+\7>&?&PT&6>-YK6\T:#P_92,K9#S.4B$@4X;#$@%00,@5^K<*Y5
MBL%.EC:..IQI/EE.//TTO%QVOTO>Z/S[B#,,/BHU,+5PDY5%=1?+UZ-/>W7;
M4]B_X(=_M,^(_B3^P/\ M!?#W6KRXU#3? WAR:ZT>29RYM(;FTO ]N">B!H0
MRCL9'[8%>2?\&S1_XS\\3_\ 8EWO_I;95^C?_!,7_@EK9_L0_LK^(O"FO7T&
MJ^*/B%$P\1W5IGR8D,3Q);0D@%DC$DAW, 2TC< 8 _*;0/V$_P!KG_@G5^TY
M/J?P]\(>+KG5M.>6UM=;T+2O[3L-2MG/\0VNFQP =D@#*0,@,H(]C#8W+\QG
MFF%PM2,/:\O*Y/E3LK2?SEKWUO8\ROA<9@HX#$8B$I>SOS6U:N[I?=I\K'VE
M_P '1W_)OWPQ_P"P_<_^DXKW7_@W[MXX/^"7/@=DC1&FOM4>1E4 R-]NF7+'
MN<*HR>P [5\V?\%'_P!GK]H?]M#_ ()S_!#^VO!NM:[\3[;4[^[\16L5I#;R
MVJEY$A+QIM5<Q"/@#/J <U]??\$8_@OXI_9]_P"">W@_PKXRT6[\/^(+"ZU!
M[BRN@!)$)+V:1"<$]58'\:^;S6=*EPI2P7M(RG"JTTFGLYZ][/H[=CV\OC4J
M<0SQ7))1E35KJVZAIVOW1\F_\%I?^"G_ ,6?A?\ M8:'\%_A'JZ^&KEH+0WM
M['%$US>7=TW[N$-(K".-4:,Y7!)=LG %>'?\%./V2/VN_ _[*%WK_P :/BKX
M=\7^#=(O[69]-MKV269;AV,,;@&UC!V^:V?FZ$]:]A_X+>?\$Q/BO\1/VHM.
M^-7PHTJY\2R26]J+VTLBK7VGW5KQ',D;']XA58\!0Q#*V1@BL7XV?##]NK_@
MIC^S%K>E^-?#>C>#]%T2.*]@T860T^_\5W4;KB,K)(S)M4N_/EH65 %)Y3Z/
M)JV"H83 U\)*C&*M[5RY?:<UU>WVK[V[*SV/&S.GBJV(Q=+$1JRD[^S4;\EM
M=^G;UVW,+]CN[O;+_@V_^-KZ?O$YURYC;9U\ICIJR_AY9?/MFM7_ (-8;32W
M\6?&.=Q'_;4=GI<<!8#>+=GN3+M[X+K#GZ)[5]0?\$@?V(?$/P\_X)Q^+/A9
M\7/#-SHC>*=6U&*[L)9HGDDM+BUMXMZM&S 'Y7P<Y!7..E?GW>_\$]?VL?\
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MRG[6-I4DD^96;Y-EKJ_0\Z.#Q']FX&/LY751MZ/1<W7L>7_\'&)_XV1WW_8
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MYB3M"Y/[$?L/_ .Y_9>_9)\ ^ KZXCNM0\-Z3'!>R1G,9N&S)*$/=1([!3W
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I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
